Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,21319,81,0.76 [0.23-2.52],0.648003526434328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,20704,78,1.09 [0.72-1.63],0.6919683456971597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,24420,84,1.12 [0.79-1.58],0.5177601250736461
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,20626,75,1.10 [0.60-2.02],0.7696991666751871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,24294,82,1.18 [0.84-1.65],0.3417900439026566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,24420,84,1.12 [0.85-1.46],0.4204035456380381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,21298,80,1.02 [0.88-1.18],0.7886143280918075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,20626,75,1.09 [0.79-1.51],0.5997354461151152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23956,85,0.92 [0.72-1.16],0.4752523099684296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20890,76,0.79 [0.53-1.18],0.2567028179033782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21290,77,0.96 [0.75-1.23],0.7396901625472669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,24324,85,0.57 [0.29-1.13],0.1100693012111838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,21298,80,1.25 [0.55-2.85],0.5937259111515255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,24111,86,1.09 [0.76-1.58],0.6378055322583243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,20813,78,0.63 [0.32-1.23],0.1756061761935899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,21197,76,1.02 [0.84-1.24],0.8280447638758949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24552,86,1.31 [0.93-1.84],0.1184849750589312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20687,81,0.87 [0.54-1.41],0.5750434122091262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,24626,89,0.93 [0.53-1.64],0.7949552188169303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,24728,86,0.88 [0.67-1.14],0.315578578830946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,21174,77,1.49 [0.88-2.50],0.1366257096317188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,20687,81,1.02 [0.79-1.31],0.9067189787464612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,20626,75,0.79 [0.40-1.59],0.5104043754863157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",24111,86,1.17 [0.80-1.72],0.4161442269132422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,20626,75,1.17 [0.84-1.64],0.3466391407547525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,24096,86,0.88 [0.46-1.69],0.6937226177072554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,24342,84,0.74 [0.32-1.73],0.486557790777533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,24552,86,0.81 [0.59-1.11],0.1916659132246709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20626,75,0.88 [0.58-1.34],0.5554711174813497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,20734,78,1.33 [0.97-1.82],0.0776543331439288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,24840,86,0.82 [0.47-1.42],0.4777241665443296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,24365,88,0.99 [0.62-1.57],0.9610653888382142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20687,81,1.26 [0.72-2.22],0.4219091437018882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24111,86,1.13 [0.61-2.11],0.689827981336687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24383,84,0.84 [0.48-1.46],0.5300779012690482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24840,86,1.13 [0.65-1.96],0.6717864416314385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24738,86,0.80 [0.42-1.53],0.5063317469121753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21197,76,1.69 [0.86-3.33],0.1297004451527779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20687,81,1.38 [0.79-2.41],0.2548472856386645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24837,89,0.99 [0.44-2.22],0.9861507148278784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24420,84,0.98 [0.62-1.54],0.9245209098113322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,24111,86,1.25 [0.78-1.99],0.354088669282783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20687,81,1.30 [0.75-2.22],0.3474527665594683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24592,89,0.68 [0.46-1.01],0.058316010637704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,21283,78,1.36 [0.71-2.61],0.3508872233580409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,20704,78,2.67 [1.44-4.97],0.0018955936154567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,21290,77,0.97 [0.56-1.69],0.9251069026217652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23956,85,1.10 [0.67-1.80],0.7009741951334263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,20813,78,1.15 [0.84-1.56],0.3861987362902214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,24342,84,1.08 [0.60-1.93],0.8021320868306815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,20813,78,1.14 [0.66-1.95],0.6441852841939328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21197,76,0.95 [0.62-1.43],0.7918978079844554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24639,90,0.94 [0.48-1.83],0.8537756810388784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24700,89,1.02 [0.54-1.93],0.9424937917710592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,21290,77,1.12 [0.52-2.40],0.7660815320224408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,24420,84,1.04 [0.75-1.45],0.809509891428618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,24552,86,0.88 [0.43-1.80],0.7227945126906867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,20634,75,0.79 [0.54-1.15],0.2170279872262331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,20813,78,0.73 [0.53-1.00],0.0527986048332359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,24111,86,0.86 [0.68-1.09],0.2073695643824277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,21319,81,1.23 [0.89-1.69],0.2099890965057513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,24760,86,1.78 [0.84-3.77],0.1296699486501851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,20626,75,0.83 [0.58-1.19],0.3104764054724224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,20813,78,0.83 [0.63-1.08],0.1702072370303411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,21319,81,1.34 [0.45-4.05],0.5983181678912186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,24306,84,0.84 [0.62-1.13],0.2410026633458426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,20634,75,0.93 [0.73-1.17],0.5146580530639994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,24472,89,1.30 [0.82-2.08],0.2684969564589859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,23762,81,1.22 [1.00-1.48],0.0453147061446333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,23925,85,1.15 [0.84-1.56],0.3820903356557296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,24639,90,1.38 [0.80-2.37],0.2483364861907161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,24840,86,1.04 [0.73-1.50],0.8158212462259936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,21298,80,1.11 [0.43-2.88],0.8319223873710178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,24552,86,0.92 [0.72-1.19],0.5318346523787828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,24552,86,1.20 [0.92-1.58],0.1790433406851537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20704,78,1.11 [0.58-2.13],0.7517799195357722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,20704,78,0.94 [0.44-1.99],0.8667523133529672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21174,77,0.95 [0.68-1.33],0.7592885451974177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,21298,80,1.76 [0.83-3.76],0.1423568545690978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,24496,88,0.89 [0.71-1.11],0.2906868125307048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",20705,76,0.82 [0.60-1.12],0.2159191423568794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,23956,85,0.84 [0.58-1.21],0.3477630770494586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,20704,78,1.22 [0.89-1.68],0.2197712238049019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24375,83,1.07 [0.89-1.28],0.4701968240520243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,24552,86,1.10 [0.82-1.48],0.5054228332442751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",21233,77,1.04 [0.85-1.27],0.7056185638342244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,20813,78,1.99 [1.10-3.63],0.023602983528014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,23956,85,0.98 [0.76-1.27],0.9045717578280338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,20705,76,0.79 [0.53-1.18],0.2538061058322134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,24111,86,1.08 [0.77-1.52],0.6416429971094901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,20687,81,0.86 [0.62-1.21],0.3907548969468803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,23961,82,1.22 [0.91-1.64],0.1787082210706483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,21257,77,1.06 [0.90-1.26],0.4694592955582334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,23828,84,1.18 [0.85-1.64],0.3297160997955265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,24837,89,0.69 [0.26-1.83],0.4599594572821649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,24534,88,0.87 [0.60-1.25],0.4520482094167812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",21174,77,1.26 [0.90-1.75],0.1788945972376322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24501,85,1.04 [0.78-1.39],0.7861448686341574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21257,77,0.94 [0.59-1.50],0.7958726505620426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,20890,76,0.79 [0.45-1.37],0.3974484224015089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,20687,81,1.13 [0.95-1.34],0.169653659529151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",24420,84,1.15 [0.97-1.36],0.109508130280929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,24096,86,0.54 [0.24-1.23],0.1430840201575373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,24729,86,1.02 [0.37-2.78],0.9677201255412914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21283,78,2.78 [1.27-6.10],0.0105438523845332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,23961,82,1.05 [0.79-1.41],0.718688225026751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,20705,76,0.66 [0.38-1.12],0.1254481837831512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,24420,84,0.89 [0.38-2.08],0.7855566605234994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,24096,86,1.05 [0.70-1.56],0.8251187631692367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,20813,78,0.70 [0.40-1.24],0.2205147742677931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,21107,77,0.89 [0.55-1.44],0.6345544585419675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,21233,77,1.02 [0.75-1.38],0.916935311360889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19960,74,0.97 [0.62-1.52],0.90538313704539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,23628,85,0.84 [0.56-1.27],0.4199593989768628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,22886,81,0.98 [0.65-1.48],0.9179672074861324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,24442,90,1.24 [0.73-2.09],0.4327790940572471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,24461,89,1.07 [0.86-1.34],0.5445837128993738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,24760,86,1.23 [0.75-2.01],0.4174452223478621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,24189,83,1.75 [0.90-3.38],0.0973251267324772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,24557,89,0.69 [0.43-1.11],0.1299316015234435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,24531,90,1.62 [0.95-2.76],0.0782457704260468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,24603,89,1.32 [0.88-2.00],0.1823007226169046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,24760,86,1.22 [0.73-2.03],0.4412436298861476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,20626,75,0.81 [0.55-1.17],0.2581201882787085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20687,81,1.11 [0.85-1.44],0.4480028279933253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,20537,77,0.92 [0.62-1.39],0.7008127345621743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,23956,85,0.79 [0.54-1.15],0.2196148830543196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20704,78,1.25 [0.81-1.93],0.3066422166134722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,24557,90,0.58 [0.29-1.17],0.1294212302685945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,20684,78,1.07 [0.68-1.66],0.7755287365137334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,23961,82,1.15 [0.90-1.45],0.2580889184871219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,24487,85,1.00 [0.75-1.32],0.9834961900938168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,20407,77,1.14 [0.85-1.51],0.3773534573328699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,24738,86,1.13 [0.87-1.47],0.3711068249382554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,24428,86,1.19 [0.93-1.53],0.1699820271768516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,23887,81,0.95 [0.49-1.86],0.8842145771713504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],24096,86,1.17 [0.87-1.57],0.2911690827378701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,24602,90,1.48 [0.79-2.77],0.2207720124042841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,21174,77,0.93 [0.71-1.22],0.6021040307515435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,20705,76,1.08 [0.71-1.67],0.7102685670532316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,21197,76,1.01 [0.76-1.33],0.9704228032071464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,21233,77,1.00 [0.63-1.57],0.9900474495222448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24420,84,1.05 [0.70-1.56],0.8228633932328291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,21141,80,0.99 [0.53-1.84],0.9779411639688452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24695,86,0.84 [0.60-1.17],0.2923419333450505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,24552,86,0.78 [0.54-1.14],0.2014385557148462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,21319,81,1.41 [0.73-2.73],0.3035936281299675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,21298,80,0.94 [0.61-1.47],0.7960139618631146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,21319,81,1.26 [0.74-2.14],0.3977412111828123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,21298,80,1.30 [0.50-3.37],0.5908397444120617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,20704,78,1.02 [0.61-1.69],0.9476732326176828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,21277,81,1.01 [0.57-1.77],0.9812076660040676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,20319,78,1.35 [0.93-1.96],0.1148549557297358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,21319,81,1.10 [0.85-1.41],0.4679246821304107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,21298,80,0.86 [0.34-2.17],0.7558350911631174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,24534,88,1.14 [0.68-1.92],0.6210027166425416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,21298,80,0.89 [0.61-1.30],0.5322713730359172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,24573,90,0.80 [0.41-1.58],0.5206966531627684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,24491,87,1.05 [0.79-1.39],0.7200614756685322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,20813,78,1.03 [0.85-1.25],0.7670146324398117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,24356,84,1.44 [0.94-2.20],0.0904863574377007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,20890,76,0.95 [0.68-1.33],0.7719224134786711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,24420,84,1.43 [0.95-2.16],0.0833684971799037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,21197,76,0.88 [0.73-1.07],0.2130667466218515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,21257,77,1.21 [0.89-1.64],0.2166911675701926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,24425,86,0.89 [0.62-1.28],0.5399885996503839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",21174,77,1.24 [0.80-1.92],0.3369235004862043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,23956,85,1.04 [0.69-1.57],0.8376278950672453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,23956,85,0.99 [0.73-1.36],0.9748840312350536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,20890,76,0.54 [0.25-1.19],0.1255721058084579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,20813,78,1.10 [0.85-1.44],0.4585434644318581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,20537,77,1.13 [0.86-1.47],0.3908645408465143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,21233,77,1.09 [0.86-1.38],0.4940304181689363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,21257,77,0.94 [0.75-1.19],0.616559729037381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,24530,85,1.02 [0.85-1.23],0.8003323746705986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,20634,75,0.84 [0.60-1.16],0.2852956406885926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,20634,75,0.52 [0.28-0.98],0.0421828324967053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,23961,82,0.83 [0.50-1.40],0.492746678945806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,20626,75,1.21 [0.90-1.63],0.2033792459228393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20626,75,1.08 [0.63-1.83],0.7890639692543409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,20634,75,0.95 [0.65-1.40],0.8022280413222345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,24096,86,0.78 [0.45-1.36],0.3839839857779729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20626,75,0.96 [0.61-1.52],0.8583512024440119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,24534,88,1.31 [0.87-1.98],0.198540201599032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,24420,84,1.05 [0.74-1.48],0.7854398639813099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,24602,90,1.17 [0.68-2.03],0.5710984557832439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,20634,75,0.82 [0.53-1.26],0.366114397675136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,24096,86,0.93 [0.60-1.44],0.7370423857152106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,21104,76,1.09 [0.69-1.71],0.7192148680486793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,24383,84,0.94 [0.67-1.34],0.7516651119128093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,24383,84,1.43 [0.75-2.72],0.277478689324972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,21298,80,1.26 [0.55-2.87],0.5901430549539862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,21290,77,1.10 [0.51-2.39],0.8037688578803255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,21257,77,1.04 [0.76-1.43],0.7976443780639014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,20704,78,1.06 [0.86-1.32],0.5617429734693637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,20626,75,0.80 [0.60-1.07],0.1264142117836502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,23961,82,1.27 [1.05-1.53],0.0127938436537698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,20537,77,1.62 [0.96-2.72],0.0690733290107961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,21197,76,1.05 [0.82-1.36],0.6808471122199533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,23956,85,1.09 [0.80-1.50],0.5860619279852939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,24592,89,1.11 [0.86-1.44],0.4349085769927253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20626,75,0.68 [0.38-1.23],0.2029817143256912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20626,75,1.08 [0.53-2.20],0.8339999667980411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20626,75,0.85 [0.47-1.55],0.5995529090483313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,20537,77,1.10 [0.67-1.81],0.7064851642976151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,20626,75,0.97 [0.69-1.38],0.8800905063429314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",20626,75,1.06 [0.71-1.59],0.7634340707358018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",24639,90,1.07 [0.90-1.27],0.426110735068359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",23961,82,1.08 [0.68-1.72],0.7421389240210788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,23956,85,0.79 [0.47-1.34],0.3892354421324603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,24420,84,0.69 [0.31-1.55],0.375132889115552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,23913,81,1.13 [0.85-1.50],0.4156682567935112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,20704,78,1.16 [0.87-1.55],0.3001560532713355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,20626,75,1.08 [0.87-1.34],0.492976099420459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21197,76,1.17 [0.65-2.11],0.6104964733123771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",21319,81,0.63 [0.17-2.26],0.4755041224848866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,23961,82,1.13 [0.86-1.48],0.3833957978553005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,20634,75,0.98 [0.79-1.21],0.8400439035873734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,21257,77,1.17 [0.77-1.77],0.4601650266220163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,21233,77,1.17 [0.83-1.64],0.3641622165615368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,24530,85,1.06 [0.87-1.30],0.5367546693323109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,24602,90,1.07 [0.54-2.13],0.8360662472060503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,21257,77,0.93 [0.63-1.38],0.7177355720665186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,23792,86,0.98 [0.77-1.26],0.8799029103314219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21319,81,1.03 [0.56-1.89],0.9282455620143274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20626,75,1.75 [0.70-4.35],0.2299570185402082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20704,78,1.10 [0.60-1.99],0.7632968574276724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24639,90,0.95 [0.47-1.90],0.8776394673994974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24534,88,0.68 [0.31-1.47],0.3228399639796094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,20687,81,1.61 [0.88-2.96],0.1228088946368327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,24530,85,1.06 [0.82-1.36],0.6722788202690599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,24342,84,1.18 [0.71-1.95],0.5178891376378781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,20687,81,1.34 [0.93-1.92],0.1158340277284995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,24111,86,1.39 [0.84-2.30],0.2013878910766611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23956,85,1.01 [0.75-1.37],0.9281303180464426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23956,85,1.09 [0.56-2.12],0.7896768589499388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,24530,85,1.05 [0.88-1.26],0.5921044341058226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21233,77,1.15 [0.89-1.49],0.275761018970891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,20705,76,1.14 [0.92-1.42],0.2147202921939458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,23923,81,1.12 [0.91-1.39],0.2830759767309866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,24534,88,0.62 [0.27-1.40],0.2492830768281419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,24383,84,0.86 [0.49-1.52],0.6074545269801124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21290,77,1.42 [0.76-2.62],0.2695188937716002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20634,75,1.07 [0.72-1.58],0.7349756710191326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,20900,80,0.60 [0.28-1.30],0.1979335537972001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21197,76,1.29 [0.93-1.79],0.1211191139669807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,21233,77,1.11 [0.89-1.37],0.3632952064083709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24530,85,1.04 [0.67-1.62],0.8497000182132154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,20687,81,0.88 [0.60-1.28],0.4929814658828239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,20537,77,0.94 [0.66-1.33],0.7220327234811516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,21174,77,1.12 [0.72-1.74],0.6042907073973124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,24530,85,1.03 [0.84-1.27],0.7618736363402173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,21283,78,1.04 [0.80-1.35],0.7578963850659133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,20704,78,1.08 [0.76-1.53],0.685441089847945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,20537,77,1.54 [1.16-2.05],0.0030837866389854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,21283,78,0.96 [0.74-1.23],0.7414919629913548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,23923,85,1.00 [0.85-1.17],0.9742373242605078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,20634,75,1.12 [0.84-1.50],0.4242604241972454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20626,75,1.78 [0.77-4.12],0.1756911371047098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,24530,85,1.07 [0.82-1.42],0.6090205357861032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,24534,88,1.03 [0.83-1.26],0.8080482477158101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,23956,85,1.19 [0.89-1.59],0.2498677307934361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,24837,89,1.22 [0.69-2.17],0.4960739703867987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,20687,81,2.04 [1.47-2.81],1.6350800381794696e-05
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20634,75,1.01 [0.75-1.36],0.9344354045816764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21233,77,0.99 [0.58-1.68],0.9727201180059488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,24534,88,1.03 [0.77-1.36],0.861595106296397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,20813,78,0.67 [0.32-1.41],0.2928797036748407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,24342,84,1.02 [0.67-1.55],0.9278328959405828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,24064,86,1.22 [0.76-1.95],0.4166536135177546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,20813,78,0.85 [0.32-2.24],0.7414808992794867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21290,77,1.57 [0.95-2.59],0.0786599412770875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20687,81,1.28 [0.82-1.99],0.2748864446619538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,24111,86,1.23 [0.54-2.79],0.6165142790408618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,20634,75,1.19 [0.84-1.70],0.3279793307300014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,20704,78,1.19 [0.80-1.77],0.380804643921323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,19968,75,0.99 [0.80-1.22],0.930071036733436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,24493,87,0.96 [0.71-1.30],0.8090162292476759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,21257,77,0.87 [0.59-1.28],0.4769911215110026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,20999,76,0.99 [0.81-1.21],0.9142070949690836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,20890,76,0.94 [0.45-1.98],0.8757055592846162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,20634,75,1.33 [0.77-2.29],0.3013335219548503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,20626,75,1.14 [0.78-1.66],0.500804246102853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,20626,75,1.31 [0.73-2.35],0.363932931708701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,23961,82,1.30 [0.84-2.00],0.2377261290449239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,20634,75,1.17 [0.74-1.85],0.5027496918006295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,21257,77,0.95 [0.53-1.69],0.8587737369904438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,24792,86,0.82 [0.31-2.15],0.6843874662827132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,20537,77,1.05 [0.56-2.00],0.8711811668626581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24776,86,0.76 [0.56-1.03],0.0734443824255941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,24776,86,0.88 [0.60-1.29],0.4980842642032963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,23956,85,1.07 [0.83-1.37],0.608054851019454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,21319,81,0.80 [0.29-2.16],0.6542737024182737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,20537,77,1.02 [0.81-1.30],0.8415597367493167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,21136,77,1.28 [0.82-1.98],0.2718989964587139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24639,90,1.09 [0.52-2.29],0.8269345315973987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,24530,85,0.97 [0.57-1.63],0.8962721475095817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,20537,77,1.15 [0.70-1.91],0.5752591229481764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,23961,82,0.85 [0.60-1.19],0.345168853305021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,20626,75,1.89 [1.14-3.13],0.0134230350475249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,24710,86,0.68 [0.29-1.59],0.3744175059395184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21257,77,1.16 [0.90-1.49],0.2624848268888001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,20687,81,0.68 [0.40-1.15],0.1533979097094523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24602,90,0.85 [0.55-1.33],0.4783105594088067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20813,78,1.42 [0.78-2.59],0.2556493043195176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21257,77,0.75 [0.36-1.57],0.4410297123250779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20774,78,1.40 [0.86-2.28],0.1702622091659172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,21319,81,1.91 [0.96-3.79],0.0636211795999857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,21283,81,0.75 [0.26-2.20],0.6013907945886601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,21319,81,1.12 [0.41-3.07],0.831033772368974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,24573,90,1.01 [0.46-2.21],0.9791914991550552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,23913,81,0.96 [0.60-1.54],0.8811149118120055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,20705,76,1.10 [0.77-1.56],0.60700045752062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,20259,79,1.34 [0.94-1.93],0.1090193205999709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,24592,89,1.22 [0.77-1.94],0.3963418767094634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,21319,81,1.79 [0.52-6.16],0.3562756522343789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,20832,80,0.98 [0.50-1.93],0.958250986111092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,21233,77,1.28 [0.64-2.57],0.4813318207513224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,21319,81,1.55 [0.77-3.12],0.2228239377317847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,21298,80,0.89 [0.60-1.31],0.5569788072527068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,21197,76,1.04 [0.79-1.36],0.79002718811216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,23969,87,1.03 [0.75-1.41],0.875349489309902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,23956,85,0.84 [0.41-1.69],0.6181787622178523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,24420,84,1.26 [0.70-2.25],0.4371444556714583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,24258,85,1.10 [0.92-1.33],0.3034170493753643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,24760,86,0.65 [0.38-1.12],0.1242920063052692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,24463,88,1.02 [0.78-1.34],0.8958351462800646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,24795,89,0.94 [0.69-1.28],0.7084678079038029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,24837,89,1.57 [0.73-3.39],0.2469947046139742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",24111,86,0.84 [0.67-1.05],0.1205593507397166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,24455,86,0.95 [0.70-1.28],0.7195214007620063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,20890,76,0.68 [0.33-1.42],0.3029050797704068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,20687,81,1.69 [1.05-2.70],0.0303968192672631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,24760,86,0.74 [0.46-1.17],0.1997505800642366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,20705,76,0.87 [0.61-1.25],0.4582782893781602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20634,75,0.70 [0.32-1.52],0.3684581504465716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20626,75,1.13 [0.82-1.56],0.4661580431399944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20634,75,1.04 [0.72-1.49],0.8350953610429094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21257,77,1.13 [0.88-1.46],0.3334472256368164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,20767,78,1.11 [0.90-1.37],0.3248674010921897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,20705,76,0.69 [0.36-1.31],0.2557450398765588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,24420,84,1.12 [0.70-1.79],0.648130463731474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,23961,82,1.18 [0.60-2.31],0.6354190773868518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,24335,83,1.15 [0.86-1.54],0.3503613685605632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,21233,77,1.00 [0.57-1.76],0.9879774367951172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24690,86,1.01 [0.84-1.21],0.9436559502666626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20704,78,1.02 [0.77-1.35],0.8905361741211945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,20626,75,1.16 [0.68-1.96],0.5855333669017904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23956,85,1.15 [0.77-1.74],0.4956316184669008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20705,76,0.88 [0.57-1.36],0.5733094480273898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21257,77,0.93 [0.75-1.14],0.4635429803575439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24483,86,1.34 [0.51-3.49],0.549664802432634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,24389,86,0.80 [0.58-1.11],0.1809762984051581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,21174,77,0.85 [0.46-1.59],0.6179725567584318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,21233,77,1.01 [0.81-1.26],0.927795820959072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,23961,82,0.82 [0.55-1.22],0.3247810790338979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,20705,76,1.25 [0.77-2.03],0.3711559619096014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,23961,82,0.85 [0.63-1.14],0.26567680237532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,23961,82,1.11 [0.85-1.46],0.4364552478339754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,24530,85,1.07 [0.81-1.40],0.6480264337989957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,24837,89,1.18 [0.95-1.46],0.1267059745821533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,20890,76,1.06 [0.94-1.20],0.3095623061947186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,21233,77,1.15 [0.89-1.48],0.2845986740366354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,24697,86,1.03 [0.77-1.38],0.858972330840143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,20687,81,1.31 [0.99-1.73],0.0626360579567816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,20626,75,0.94 [0.58-1.52],0.7886125398128114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,20970,77,0.89 [0.59-1.34],0.5667287441131252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,24524,86,0.98 [0.74-1.29],0.8759658982509055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,20634,75,0.70 [0.50-0.99],0.0418262481489395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,24760,86,0.78 [0.43-1.44],0.4333502653075175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,20704,78,0.80 [0.50-1.27],0.3456701322075448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,20626,75,0.76 [0.39-1.48],0.4166374994472129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24383,84,1.06 [0.82-1.36],0.6805511863941283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,21233,77,1.06 [0.74-1.50],0.7564403255736161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,21174,77,1.39 [0.95-2.04],0.0852470451544159
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,20705,76,1.54 [0.73-3.23],0.2567606475697518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,21257,77,1.10 [0.86-1.42],0.4427415953155449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,24552,86,1.24 [0.71-2.19],0.452340279671941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20704,78,1.14 [0.81-1.61],0.4461880005414148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,24840,86,0.90 [0.55-1.48],0.668425631840635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,24800,86,0.98 [0.74-1.29],0.8655070604875295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,24442,90,1.16 [0.74-1.81],0.515316123665132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,24837,89,1.62 [1.10-2.39],0.0139209332389887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,24837,89,0.96 [0.66-1.40],0.8457065801771299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,24474,89,0.97 [0.79-1.19],0.7451186868026285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,24177,88,1.09 [0.85-1.39],0.4906653051704198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,24776,86,1.01 [0.86-1.18],0.9361555070682968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,24342,84,1.15 [0.80-1.65],0.4451319759888729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,24840,86,0.87 [0.68-1.11],0.2657439106269325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,24639,90,1.26 [0.84-1.91],0.2681771753521605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,24249,89,0.77 [0.53-1.12],0.165914505991268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,24639,90,1.06 [0.68-1.67],0.7868328986060965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,24603,89,0.88 [0.70-1.10],0.2512877284901632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,24840,86,1.18 [0.81-1.71],0.3967978305212448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,24530,85,1.02 [0.83-1.25],0.8571092732315561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,24552,86,1.02 [0.75-1.39],0.885729837514921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,24457,85,1.10 [0.80-1.51],0.5661200871135439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24530,85,0.96 [0.66-1.40],0.8493521666013126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,24551,90,0.90 [0.66-1.23],0.5240191810018098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,24602,90,1.10 [0.92-1.32],0.2761109964009116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,24530,85,0.93 [0.66-1.31],0.6917384740799551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,24729,86,0.89 [0.66-1.21],0.4705927086246055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,24386,84,1.26 [0.97-1.63],0.0864690313386713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,24536,89,0.96 [0.70-1.32],0.8101651671090049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,24796,89,0.83 [0.46-1.50],0.5348720852034448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,24760,86,0.82 [0.50-1.35],0.4414174786022378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,24534,88,1.08 [0.66-1.76],0.7640412945843971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,20890,76,1.06 [0.59-1.91],0.8448654197231602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,20687,81,0.98 [0.78-1.24],0.863003411325924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,24383,84,1.19 [0.80-1.77],0.390262143553891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,23956,85,0.99 [0.64-1.52],0.9457678316460894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,21197,76,0.68 [0.44-1.07],0.092374434070534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,24534,88,0.67 [0.38-1.19],0.1706065499133688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,23992,88,1.29 [0.82-2.03],0.2719604570224312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,24840,86,0.91 [0.60-1.38],0.6485557233538594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24602,90,1.00 [0.65-1.54],0.9936776893212336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,24534,88,0.86 [0.40-1.85],0.7049403914537938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,20705,76,0.95 [0.52-1.73],0.8726946721439549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,24499,88,0.86 [0.76-0.98],0.0242266528829368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,24592,89,0.46 [0.25-0.87],0.0171169105895685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,20626,75,0.81 [0.42-1.55],0.5160074200879299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,24530,85,1.00 [0.47-2.11],0.993047653574887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,24449,85,0.90 [0.51-1.58],0.7171757285744347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,24004,83,0.66 [0.40-1.11],0.1183542436285578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,24580,89,1.28 [0.79-2.05],0.3142016224543583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24840,86,1.26 [0.79-2.02],0.3286705327554991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,20687,81,1.08 [0.66-1.79],0.7509961692423524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,24840,86,0.93 [0.45-1.89],0.8340611078031912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,21283,78,1.18 [0.68-2.03],0.5517841705688753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24592,89,0.78 [0.48-1.28],0.332999630707732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,24383,84,1.03 [0.57-1.87],0.911287240686414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,24518,89,1.31 [0.76-2.27],0.3265845330874435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23956,85,1.01 [0.58-1.75],0.9753782881724934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,24552,86,1.18 [0.88-1.57],0.2732781468575537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,20813,78,0.93 [0.44-1.96],0.8399358552513233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,24776,86,1.04 [0.59-1.83],0.9044954247985612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,24685,86,1.04 [0.64-1.71],0.8708360555496557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,24760,86,1.22 [0.85-1.74],0.2820383570723981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,24534,88,1.40 [0.84-2.34],0.1990518010388179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,24420,84,0.97 [0.49-1.93],0.9381286329786044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,24592,89,0.91 [0.72-1.14],0.3946513465717983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,24680,85,1.59 [0.73-3.48],0.247188370607232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,20687,81,1.50 [0.96-2.33],0.0721890878829225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24420,84,1.51 [0.80-2.86],0.2041628702177077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,20634,75,0.59 [0.27-1.30],0.1921646964632549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20890,76,0.93 [0.49-1.78],0.8358586243307895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,20687,81,0.76 [0.54-1.06],0.1059705408853557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,24486,85,1.13 [0.58-2.22],0.7126620196594291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,24515,89,1.15 [0.80-1.65],0.4515402111819692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,24840,86,1.13 [0.89-1.44],0.3046207265197719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,24357,90,1.10 [0.57-2.10],0.7824952722039942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24603,89,1.09 [0.58-2.08],0.7864810609052517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24729,86,1.13 [0.64-2.00],0.6716120299048877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,23664,85,0.96 [0.44-2.05],0.9059748549875766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,24466,88,1.10 [0.37-3.26],0.8587745640513759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,23622,87,1.13 [0.47-2.76],0.7837087645252778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,21209,81,0.84 [0.53-1.32],0.4514244418816155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,24792,86,1.11 [0.78-1.58],0.5693925050024844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,24342,84,1.00 [0.69-1.45],0.9843847082387182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,24419,86,1.11 [0.89-1.38],0.3442321227387399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,20653,81,0.94 [0.56-1.57],0.8155001886773126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24530,85,0.92 [0.58-1.44],0.7062427650922318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20813,78,1.27 [0.75-2.15],0.3820842553763718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24776,86,0.91 [0.51-1.62],0.7513911015987425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24840,86,0.90 [0.56-1.44],0.6599500696658129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,21290,77,1.34 [0.69-2.59],0.3850361021663763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,20890,76,0.66 [0.34-1.28],0.2194527672907881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24530,85,1.56 [0.89-2.74],0.1185957723446158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,24530,85,1.08 [0.59-1.97],0.8103046627973397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,21197,76,0.93 [0.45-1.92],0.8357213264299107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,24776,86,1.12 [0.76-1.65],0.5656098771124106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,23564,82,0.93 [0.49-1.79],0.8328802089051026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,24534,88,1.64 [0.62-4.36],0.3207140343056549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,24534,88,1.28 [0.59-2.78],0.5362782935434136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,21256,77,0.97 [0.62-1.51],0.892922915854064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,21233,77,1.35 [0.59-3.08],0.4758988072532824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,20537,77,1.14 [0.84-1.54],0.3973687048409489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,20537,77,0.94 [0.54-1.64],0.8177536493086087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,21161,76,1.11 [0.82-1.50],0.509947507357239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,23956,85,0.91 [0.65-1.25],0.5524239543723797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,24592,89,1.14 [0.91-1.42],0.2458535716429454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,21197,76,0.98 [0.79-1.21],0.8386103486440146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,24383,84,1.32 [0.93-1.88],0.1168083007032654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,23681,85,0.99 [0.62-1.59],0.967851976272498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,24728,85,0.97 [0.69-1.36],0.8391802120443026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,24552,86,0.94 [0.70-1.25],0.6667032328455951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,24552,86,1.35 [0.78-2.32],0.2831774935717529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,20890,76,1.03 [0.48-2.21],0.9438393139437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,21233,77,1.10 [0.50-2.44],0.8088586958489979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24776,86,1.12 [0.65-1.94],0.6760820681134261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,20634,75,0.70 [0.41-1.21],0.2028417701882407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,24837,89,0.70 [0.37-1.33],0.2782639608918142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,24552,86,0.77 [0.46-1.28],0.3146152066698168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,23961,82,1.09 [0.70-1.71],0.7006566470037745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,24420,84,0.87 [0.66-1.14],0.2987354368404282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,24552,86,0.87 [0.54-1.40],0.5546838132017089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,20537,77,1.50 [0.83-2.70],0.1763505026694692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21257,77,0.86 [0.58-1.27],0.4495857017919239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,20634,75,0.74 [0.45-1.23],0.2424781477794951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,24420,84,1.13 [0.94-1.35],0.1967052298542543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24420,84,1.11 [0.90-1.37],0.3133914991335538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,24420,84,1.23 [0.70-2.18],0.4719181267184787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24562,89,0.94 [0.46-1.91],0.8554210101683597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,24759,86,1.06 [0.68-1.67],0.7868950541547755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24554,89,0.44 [0.27-0.72],0.0011074050592468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21197,76,1.14 [0.88-1.48],0.3290146039749246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20890,76,1.14 [0.87-1.50],0.3469788472388033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21197,76,0.79 [0.45-1.39],0.407839251614558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20890,76,1.18 [0.76-1.83],0.4597515246704405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24530,85,1.11 [0.89-1.37],0.3675345615004146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23956,85,0.89 [0.58-1.36],0.5894333716949357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23606,84,1.10 [0.81-1.50],0.5326687021301255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21283,78,0.79 [0.46-1.35],0.3888042978184436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,24111,86,0.90 [0.61-1.32],0.581437006811654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,20687,81,1.41 [0.97-2.03],0.0709138095909434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,24111,86,0.77 [0.45-1.32],0.3498712028265485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,21283,78,0.83 [0.58-1.17],0.2885906969148809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,24792,89,0.89 [0.64-1.23],0.478923883464036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20813,78,0.79 [0.36-1.74],0.5562933537689364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,20687,81,0.96 [0.48-1.93],0.9165417167596924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,20634,75,0.72 [0.44-1.17],0.184736420839463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,20890,76,0.94 [0.63-1.41],0.7799116599840503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,20890,76,1.12 [0.84-1.48],0.4518262967983488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,20626,75,0.79 [0.44-1.44],0.4443348597392714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,20537,77,1.11 [0.71-1.76],0.642062156133285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,24096,86,0.89 [0.64-1.26],0.5242799797821653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,20704,78,0.88 [0.65-1.17],0.3772562767527917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,23956,85,1.26 [0.99-1.62],0.05946439130959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,20890,76,0.92 [0.60-1.43],0.7227095502179679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,20537,77,0.82 [0.44-1.52],0.529248024646856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,23918,86,1.29 [0.99-1.68],0.0626763558031524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,23956,85,0.92 [0.67-1.24],0.574637670261944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,23961,82,1.11 [0.81-1.53],0.5006132139443754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,24576,88,0.90 [0.71-1.14],0.3889410137085057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,24420,84,0.87 [0.61-1.25],0.4612519462283923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,24420,84,0.95 [0.72-1.26],0.7346025914962098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,23961,82,1.08 [0.82-1.43],0.579512616100984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,21197,76,1.18 [0.90-1.54],0.2196525950951783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,20927,79,0.87 [0.45-1.67],0.6734355293360514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,23956,85,0.70 [0.44-1.12],0.1369623078095879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,21319,81,1.71 [0.69-4.21],0.245271718479383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,20095,75,1.02 [0.39-2.65],0.969796138011362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,21167,81,0.95 [0.66-1.37],0.7753723050582175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,21280,81,0.92 [0.69-1.23],0.591483791175071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,21030,80,1.54 [0.89-2.64],0.1199132821290135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,21319,81,1.78 [0.62-5.09],0.2813629887353527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,21319,81,0.76 [0.28-2.05],0.5877098122226199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,24534,88,1.08 [0.84-1.38],0.5607559529334367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21298,80,1.00 [0.59-1.71],0.989816150693757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,20705,76,1.38 [0.89-2.15],0.1499940654429613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,24552,86,1.23 [0.79-1.91],0.3684428217386409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23956,85,0.98 [0.72-1.35],0.9259007487421363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,20813,78,1.01 [0.65-1.58],0.9506997053523272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21233,77,1.34 [0.82-2.19],0.2452499218363147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,21174,77,1.58 [0.90-2.80],0.1132336130106549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,24111,86,1.25 [0.72-2.16],0.4252180923406931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,21283,78,1.18 [0.92-1.50],0.1869548053764469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,24687,85,0.76 [0.47-1.25],0.2860974756940981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,23949,89,1.11 [0.88-1.39],0.3888518005426127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,24630,89,1.09 [0.94-1.26],0.2643269514611168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,24559,90,0.61 [0.33-1.15],0.1286346971047225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,20705,76,0.95 [0.66-1.38],0.8029616742711019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,24383,84,1.05 [0.82-1.34],0.6789028480470696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,21290,77,1.12 [0.77-1.63],0.5478142584853535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,20634,75,0.86 [0.62-1.20],0.372027462628685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,24603,89,0.65 [0.36-1.18],0.1548162851125521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,24552,86,1.01 [0.71-1.44],0.954511827026531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,20705,76,1.02 [0.56-1.85],0.9424951189589192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,24592,89,1.04 [0.77-1.39],0.8017618569205518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,21283,78,1.14 [0.76-1.71],0.5175136090805402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,20890,76,0.73 [0.41-1.32],0.2961664741869757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,21197,76,1.03 [0.82-1.28],0.8229080156471141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,20705,76,0.67 [0.39-1.14],0.138847523531896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,24704,86,1.01 [0.48-2.13],0.9824789991770622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,21283,78,1.09 [0.75-1.59],0.6419546048575255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24419,88,1.03 [0.78-1.37],0.8298036149903459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,20537,77,1.07 [0.81-1.42],0.627516632679803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,24517,86,1.05 [0.79-1.39],0.7309269735966328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,24383,84,1.07 [0.63-1.84],0.797607286717564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,24486,87,1.07 [0.72-1.61],0.7281312165669389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,20687,81,1.92 [0.85-4.31],0.1158838182453727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,24534,88,1.79 [0.99-3.27],0.0555017375632805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24111,86,0.89 [0.49-1.62],0.6926915006930856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,24776,86,1.15 [0.95-1.40],0.1575849579068271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,20705,76,0.67 [0.38-1.18],0.1648898703094716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,20833,79,1.51 [0.74-3.07],0.2532623270698154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,24530,85,1.18 [0.67-2.06],0.5711674996480834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,24530,85,1.15 [0.76-1.73],0.5024362370063447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,24530,85,0.95 [0.70-1.31],0.7679552490428646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,24530,85,1.00 [0.56-1.77],0.9930314404781486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,21248,78,1.26 [0.81-1.94],0.3034603342055422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,24462,86,1.11 [0.58-2.12],0.7477226698077004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,23956,85,0.89 [0.58-1.36],0.590324972985254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,24840,86,1.22 [0.83-1.80],0.3052324012431251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,20705,76,0.89 [0.53-1.50],0.6686006115608063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,20705,76,0.67 [0.31-1.48],0.3267702362789902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,20537,77,0.88 [0.54-1.44],0.6082641877563001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,24530,85,1.01 [0.86-1.20],0.8902279098986114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,24760,86,0.71 [0.27-1.81],0.4683698377203197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,20705,76,0.73 [0.37-1.45],0.3700561074078015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",24335,83,1.08 [0.89-1.32],0.4368874058281109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,24496,88,0.99 [0.76-1.30],0.9597977809562954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,23913,81,1.04 [0.61-1.79],0.8760631665695907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,23961,82,1.25 [0.91-1.72],0.1615797931148788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,24840,86,1.06 [0.66-1.69],0.8058738229712942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21233,77,1.03 [0.51-2.10],0.9298340226441416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,24111,86,1.20 [0.83-1.75],0.3321974281476382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,21319,81,1.28 [0.80-2.07],0.306388554920031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,24512,85,1.46 [0.98-2.18],0.0618206740085581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,21290,77,1.04 [0.83-1.32],0.7163675144875565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,21174,77,1.19 [0.92-1.53],0.1857810749570933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,24602,90,0.88 [0.59-1.31],0.522336454241663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,20634,75,1.22 [0.91-1.65],0.182629560758327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20665,77,1.09 [0.83-1.43],0.5518002350700312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,24111,86,1.03 [0.75-1.41],0.8551016781172458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,24420,84,1.11 [0.86-1.43],0.4153482927706786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,24552,86,1.07 [0.90-1.28],0.4232457720010195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,20634,75,0.90 [0.46-1.73],0.7420885519898983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,24837,89,0.78 [0.39-1.58],0.4909725714452954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,24760,86,0.85 [0.55-1.31],0.4686841511794869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,24534,88,0.83 [0.45-1.50],0.531878501299286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,24534,88,1.09 [0.49-2.45],0.8262829793158062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,24608,84,1.64 [0.97-2.78],0.0647115640531984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,24530,85,1.04 [0.65-1.65],0.8784711374978044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,20705,76,0.97 [0.78-1.21],0.7875795365695789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,21290,77,1.11 [0.70-1.77],0.6580387326527913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,21283,78,1.17 [0.51-2.66],0.7104492670434551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,24616,89,1.41 [0.61-3.23],0.4217739271610558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,24837,89,0.91 [0.42-1.94],0.7996972186478233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,21197,76,0.86 [0.61-1.23],0.4137393844127154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,20705,76,0.87 [0.65-1.17],0.3566291752319469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,20704,78,1.24 [0.96-1.61],0.106111046222122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,21283,78,2.06 [0.92-4.62],0.0798447313970822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,24552,86,1.74 [1.09-2.78],0.0209995644526464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,20855,76,1.22 [0.79-1.89],0.3668378417860609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,20813,78,1.59 [0.97-2.59],0.0634005074469598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,24837,89,1.06 [0.59-1.89],0.8457265977164871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,24530,85,0.98 [0.64-1.52],0.934376524557349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,20890,76,0.82 [0.47-1.42],0.4760822074514058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,24518,89,1.30 [0.61-2.75],0.4993551556959041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,20704,78,0.93 [0.66-1.33],0.6980630412763618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,21174,77,0.84 [0.47-1.50],0.5607415067298556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,24259,86,0.77 [0.43-1.36],0.3647631242581994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,23835,84,1.12 [0.89-1.41],0.329518828515688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',20626,75,1.06 [0.62-1.78],0.8397134460957717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,23961,82,0.91 [0.58-1.43],0.6682615521365627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20704,78,0.89 [0.54-1.49],0.6633872498084912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,24031,85,1.15 [0.95-1.40],0.1525741126310091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,20634,75,0.72 [0.37-1.38],0.3203604355829403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24420,84,1.23 [0.95-1.60],0.1204929979048859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,21290,77,1.75 [0.95-3.23],0.0742477609860293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,24837,89,0.98 [0.72-1.32],0.8863148814791941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,24686,85,0.93 [0.70-1.25],0.6455328738283677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,20399,77,1.07 [0.64-1.78],0.7977955870178236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,24837,89,0.96 [0.70-1.31],0.7952630567710932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,21277,81,1.83 [0.76-4.44],0.1797370021280671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,24582,86,1.01 [0.62-1.65],0.9679655273725176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,20537,77,1.54 [0.98-2.40],0.0605588322439147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,24670,84,1.26 [0.72-2.22],0.4125124983706532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20687,81,1.71 [0.89-3.30],0.1074536325869716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,24776,86,1.15 [0.87-1.51],0.3376280437753936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,21246,77,1.28 [0.68-2.39],0.449556968039538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,20626,75,0.90 [0.51-1.60],0.7305321569954264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,24718,86,1.46 [0.91-2.37],0.1192935235071116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,24592,89,1.18 [0.91-1.54],0.2123485811115835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,21290,77,1.56 [0.68-3.54],0.2929522358766613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,21213,80,0.74 [0.40-1.38],0.346414994075319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,24602,90,0.95 [0.63-1.43],0.8146815633215772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23956,85,0.99 [0.79-1.24],0.9387461467908836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,24335,83,1.13 [0.87-1.46],0.351692337933339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,20537,77,1.07 [0.73-1.55],0.7428834001190376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,20537,77,1.29 [0.59-2.82],0.5221373721028131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,24188,87,0.82 [0.50-1.34],0.4305641657572508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,20813,78,1.02 [0.57-1.84],0.9417392265952508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,24603,89,1.35 [0.95-1.90],0.0903430527082419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,23914,84,0.79 [0.62-0.99],0.0398392415022468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,24518,89,1.10 [0.56-2.17],0.7829574523689242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,24111,86,1.16 [0.88-1.52],0.2822144221290418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,24639,90,1.59 [0.63-4.04],0.3259746823346955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,24383,84,1.21 [0.73-2.00],0.4687363647755335
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,24760,86,0.90 [0.65-1.26],0.5512410475073564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,21092,80,0.31 [0.14-0.68],0.003396395105721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,24551,88,1.09 [0.92-1.30],0.3278162611414666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,24639,90,0.92 [0.45-1.90],0.8209178253271083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,23799,83,1.53 [1.15-2.03],0.0031026875547035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,24837,89,1.45 [0.77-2.73],0.2500300485876037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24383,84,0.96 [0.65-1.42],0.83368239002038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,20705,76,0.93 [0.58-1.48],0.7478466427618516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,24111,86,1.08 [0.92-1.27],0.3216690260730782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,21290,77,1.13 [0.82-1.55],0.4609323074496849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,21233,77,1.03 [0.73-1.44],0.8845681112317304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,21233,77,1.04 [0.83-1.30],0.7133569154425201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,20634,75,1.11 [0.85-1.44],0.4620132268954354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,20704,78,1.09 [0.86-1.38],0.4872053958424208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,20626,75,0.91 [0.75-1.12],0.3760374695432379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24639,90,1.09 [0.53-2.21],0.8184388070195971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,21298,80,0.82 [0.47-1.44],0.4931814932502191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,20626,75,1.70 [1.09-2.65],0.0198816037990325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24383,84,0.84 [0.60-1.16],0.2834279954458755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,20687,81,1.26 [0.76-2.08],0.3733829664228265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,24096,86,1.12 [0.76-1.65],0.5697626742117216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,20687,81,1.50 [0.82-2.76],0.1893053365442709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,21298,80,1.20 [0.66-2.17],0.555909327338022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,20687,81,1.07 [0.77-1.47],0.6973312945269863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,21257,77,0.97 [0.60-1.56],0.8905450577991859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,21283,78,0.92 [0.48-1.77],0.8061613580127925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,20634,75,0.74 [0.44-1.24],0.2472401174806587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,20626,75,1.07 [0.86-1.33],0.5565556224118811
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,18442,69,0.89 [0.70-1.14],0.3641536192849925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,24560,89,1.12 [0.56-2.25],0.7407087850100941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,24094,81,0.83 [0.57-1.20],0.3198631794320213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,23923,87,0.80 [0.53-1.20],0.2831903587621095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,24551,90,1.05 [0.87-1.27],0.6157885525096525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,24196,87,1.41 [0.94-2.14],0.0993112010118807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,20844,76,1.36 [0.96-1.93],0.0815400614342924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,21002,78,0.72 [0.35-1.48],0.3680287969332836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,24111,86,1.14 [0.92-1.41],0.2411945995576934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,21283,78,1.43 [0.65-3.13],0.3718428697002508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,21283,78,1.27 [0.72-2.25],0.4075547758792555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,20634,75,1.64 [1.12-2.39],0.0105652819942824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,24534,88,1.16 [0.83-1.63],0.3832384349317921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,24519,89,0.77 [0.57-1.03],0.0789506167347481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,21233,77,1.26 [0.91-1.72],0.159984660432932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,24527,89,0.83 [0.57-1.21],0.3303932043794805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,24467,89,1.45 [0.98-2.15],0.061642860881955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,22873,82,1.19 [0.75-1.90],0.4613204408129794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,20813,78,1.21 [0.81-1.82],0.3524970663842716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,24592,89,1.06 [0.67-1.67],0.802348969114798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,24044,86,0.93 [0.71-1.21],0.5741440842527625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,24552,86,1.41 [0.64-3.09],0.3909828670888262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,24840,86,1.62 [0.90-2.94],0.1083320433092168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,19386,66,0.71 [0.26-1.95],0.5108610618034826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,24686,86,0.77 [0.48-1.26],0.3016091090562572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,24510,90,1.15 [0.63-2.07],0.6500691024204565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,20705,76,0.85 [0.45-1.61],0.6246727406043396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21080,76,0.99 [0.70-1.40],0.955652498965572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,24383,84,0.91 [0.50-1.65],0.758505921497276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,24530,85,1.14 [0.79-1.64],0.4751947343812216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,24469,90,1.12 [0.93-1.35],0.2450894461516023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,24639,90,0.88 [0.65-1.19],0.4046705419563886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,24776,86,1.07 [0.84-1.35],0.6002837339645564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,24096,86,0.95 [0.59-1.54],0.8447236453842439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24776,86,1.08 [0.80-1.48],0.6076719066928233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,24096,86,1.12 [0.84-1.50],0.4296880549864417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,24787,89,1.60 [0.72-3.56],0.2463210468763242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,24840,86,1.21 [0.81-1.79],0.3494976290484013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,24515,89,1.04 [0.85-1.26],0.7215658165831771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,24467,86,1.07 [0.90-1.26],0.4307280105390976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,24840,86,0.99 [0.77-1.27],0.9552376907816518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,24348,85,0.94 [0.70-1.27],0.6992739337877095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24639,90,0.97 [0.73-1.30],0.8603616610138223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,20537,77,0.90 [0.64-1.25],0.5216604528162414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,20942,75,1.19 [0.82-1.73],0.3713899799327314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20626,75,0.99 [0.76-1.29],0.9163777418324224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,20537,77,0.89 [0.65-1.23],0.4916444510672653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,21283,78,0.83 [0.34-2.05],0.6823943403036536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,20813,78,1.05 [0.81-1.36],0.7327704113629552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,24760,86,1.09 [0.92-1.29],0.3297816892221747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,24639,90,1.14 [0.78-1.67],0.488318322025828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,20687,81,0.98 [0.67-1.44],0.9342711076961976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,20687,81,1.15 [0.83-1.58],0.393920845130036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24530,85,1.04 [0.89-1.23],0.6044036175326506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",24335,83,1.07 [0.82-1.40],0.5971159062636022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,21264,80,1.03 [0.85-1.26],0.7443856775221978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,24417,87,1.23 [0.98-1.55],0.07459633610975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,20687,81,1.18 [0.80-1.73],0.4150733068539866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,24639,90,1.09 [0.90-1.33],0.3817743455094595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24592,89,0.59 [0.37-0.94],0.0253631216096094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,20705,76,0.93 [0.35-2.47],0.8803237835773124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,20537,77,0.88 [0.60-1.28],0.4941916777509152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,20537,77,1.18 [0.60-2.34],0.6265345438262189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,24111,86,1.62 [0.68-3.88],0.2798924972922505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,20813,78,1.15 [0.91-1.44],0.2461083230398487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,24760,86,1.10 [0.82-1.47],0.5219051996639731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,24420,84,1.02 [0.83-1.25],0.82281572201075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,23961,82,1.18 [0.93-1.50],0.1774291735773868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24552,86,1.86 [1.04-3.34],0.0377656108808912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,20634,75,0.86 [0.62-1.21],0.384658372734209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,20537,77,0.96 [0.72-1.27],0.7608770724961947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,24592,89,0.72 [0.50-1.04],0.0821212040410301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,20626,75,1.37 [0.88-2.13],0.1587044806870492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24420,84,1.25 [0.83-1.86],0.2837761794292718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,24524,86,0.95 [0.64-1.41],0.8080535007492533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,21257,77,0.97 [0.70-1.34],0.8534330286462248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,20813,78,1.02 [0.77-1.35],0.8755895828155412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,24776,86,0.80 [0.34-1.86],0.6008317076307567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,21283,78,0.91 [0.53-1.54],0.7233351476903906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,21197,76,0.89 [0.57-1.41],0.6200693983689267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,20705,76,0.97 [0.54-1.75],0.9312370741788883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,20687,81,1.36 [0.60-3.09],0.4655464351041527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,20687,81,1.15 [0.84-1.57],0.3931131800453524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,20705,76,1.26 [0.74-2.15],0.3963693884541135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,23956,85,1.25 [0.96-1.63],0.0946997065052149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24530,85,1.13 [0.93-1.38],0.2176710944869329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,24017,85,0.67 [0.44-1.02],0.0610309799091882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,20542,81,1.24 [0.79-1.93],0.3503418856383971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,20634,75,0.72 [0.45-1.14],0.1591020709546997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,20634,75,0.54 [0.34-0.85],0.0081800678032712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,20634,75,1.03 [0.72-1.49],0.8606786508147986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,24161,83,1.03 [0.90-1.17],0.7140243498008534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,20626,75,1.08 [0.72-1.64],0.7050823586289348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,20687,81,1.22 [0.87-1.70],0.2523171294969982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,24840,86,1.13 [0.86-1.49],0.3674837722202672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,20634,75,1.28 [0.85-1.93],0.235891498548689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,20687,81,1.40 [0.97-2.02],0.0734833630725896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,24096,86,0.65 [0.37-1.14],0.1333073809628081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,20626,75,0.97 [0.59-1.60],0.9122434677168048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21174,77,0.98 [0.57-1.69],0.9526708932319607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21233,77,1.14 [0.74-1.74],0.5629717159030219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",24462,86,1.12 [0.94-1.33],0.2108378496113583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,20705,76,0.94 [0.54-1.63],0.8306099102178601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,20813,78,0.35 [0.19-0.66],0.001163115665251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,24776,86,1.14 [0.83-1.56],0.4304413565495441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,24837,89,1.12 [0.59-2.14],0.7320504618961984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,24339,83,0.98 [0.64-1.50],0.9310989036781964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,24420,84,0.92 [0.74-1.14],0.4295638911291839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,21233,77,1.01 [0.75-1.36],0.9525405006196122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,21257,77,1.15 [0.81-1.63],0.4347755325981141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,24837,89,1.13 [0.81-1.57],0.4664008447625057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,24592,89,0.60 [0.35-1.04],0.0713354770902133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,20704,78,1.04 [0.83-1.30],0.7369692246880032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,20704,78,0.99 [0.65-1.53],0.9781512243819296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,20704,78,1.05 [0.72-1.52],0.8095671558363569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,20537,77,0.79 [0.46-1.35],0.3916836192982569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,24752,86,1.12 [0.89-1.41],0.3348708819825198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,21233,77,0.88 [0.65-1.20],0.4237636281666436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,24420,84,1.16 [0.93-1.45],0.1799881891750788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,21197,76,1.26 [0.93-1.71],0.1370686317086198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,20813,78,1.13 [0.77-1.68],0.5316852153265087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,20615,78,1.12 [0.87-1.45],0.3658810456092234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,24111,86,1.04 [0.75-1.43],0.8240362202067851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,21233,77,1.13 [0.66-1.93],0.6587025892473509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,20704,78,1.09 [0.84-1.40],0.5134863759055819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,21197,76,1.27 [0.97-1.68],0.0876534852170038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,24482,89,0.78 [0.38-1.62],0.5051961663696614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,20634,75,0.79 [0.57-1.10],0.1598726301986257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,21197,76,0.97 [0.80-1.17],0.7506317694266246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,21257,77,0.98 [0.65-1.46],0.9136004114044666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,24383,84,1.07 [0.79-1.44],0.6833512419721268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,21233,77,0.94 [0.66-1.35],0.7399305216195278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24587,89,1.22 [0.86-1.75],0.2657225205177305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,20705,76,0.99 [0.54-1.82],0.981130071114394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,20634,75,1.02 [0.84-1.22],0.874873653956427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,21233,77,1.03 [0.88-1.20],0.7517429111364344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,24552,86,1.09 [0.93-1.27],0.2779461503281438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,24335,83,1.03 [0.68-1.56],0.8992156769705993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,24420,84,0.43 [0.22-0.85],0.0151407020679988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,24530,85,1.27 [0.76-2.13],0.3651292013680557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,24034,90,0.85 [0.45-1.61],0.6170008406247978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,24420,84,0.92 [0.51-1.63],0.7641934103573845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,24348,86,1.16 [0.86-1.57],0.3361832877544694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,24837,89,0.95 [0.47-1.92],0.8855932120831425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,24695,86,1.06 [0.78-1.44],0.7051309842684205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,24383,84,1.12 [0.71-1.77],0.6323742355271305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,24420,84,1.24 [0.90-1.72],0.1927718297631776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,24233,84,1.06 [0.59-1.90],0.852526828437361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,21257,77,1.15 [0.63-2.13],0.6438317381504538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,24534,88,0.69 [0.34-1.40],0.2989736065650348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,24689,86,0.65 [0.37-1.14],0.1292822133509328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,24330,84,0.85 [0.57-1.25],0.4044521475680271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,20813,78,1.12 [0.88-1.43],0.3555321599798801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,21138,77,0.89 [0.55-1.44],0.6490790699754103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,20705,76,1.08 [0.78-1.49],0.6435227387955833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24420,84,0.93 [0.40-2.13],0.8607531438790785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,21290,77,1.14 [0.83-1.55],0.4149292713618522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,24111,86,1.12 [0.88-1.41],0.3576413828957111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,21174,77,1.03 [0.62-1.72],0.9096019475987434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,20705,76,0.85 [0.59-1.24],0.4064640551749422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,23961,82,1.18 [0.98-1.42],0.0886791948359062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21197,76,1.04 [0.84-1.28],0.7162811964139184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,21233,77,1.21 [0.76-1.92],0.411685481189974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21174,77,1.24 [0.87-1.77],0.2327297105322783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,20705,76,1.14 [0.89-1.46],0.3063853201966987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,21174,77,1.47 [0.92-2.34],0.1031737598292922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24383,84,1.07 [0.88-1.31],0.4977568999641143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24728,86,0.46 [0.24-0.87],0.0170825832343963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,23961,82,0.87 [0.50-1.53],0.6272623913391198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21290,77,0.88 [0.65-1.19],0.4092881050624056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20704,78,1.03 [0.83-1.29],0.7851481994118596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,20626,75,1.14 [0.82-1.58],0.4282993164766825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,20719,80,1.26 [0.69-2.30],0.4548247082759767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,20634,75,1.15 [0.79-1.68],0.4679024668844479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24760,86,0.89 [0.52-1.50],0.6552074313716251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24530,85,0.86 [0.70-1.06],0.1493833520140291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,21174,77,1.01 [0.68-1.50],0.9517016036714568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20626,75,1.26 [0.75-2.11],0.3779535020005636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,21257,77,1.19 [0.92-1.54],0.175155962382055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,24111,86,0.83 [0.49-1.41],0.4939003695271939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,20704,78,1.31 [0.62-2.80],0.48147511328472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,20687,81,1.02 [0.64-1.64],0.9205827327663736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,21290,77,1.01 [0.80-1.27],0.9594020049444232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21197,76,0.80 [0.33-1.91],0.611877615348347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,20890,76,1.15 [0.64-2.07],0.6406702546393384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24553,90,0.93 [0.50-1.71],0.8151146944656029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,21257,77,1.30 [0.73-2.32],0.3651865486769677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24490,88,1.31 [0.65-2.67],0.4527379728276012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24342,84,1.60 [0.82-3.13],0.1720609858445135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,20705,76,1.03 [0.72-1.47],0.8792784593387516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,24477,89,1.11 [0.93-1.33],0.2578711552347535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,23956,85,0.95 [0.58-1.56],0.8472532857817232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,21197,76,0.98 [0.49-1.99],0.9634346988304816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,24837,89,0.44 [0.14-1.39],0.1636677120852017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24530,85,1.02 [0.73-1.42],0.912983471301714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,21290,77,1.04 [0.78-1.38],0.7825698433812336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,20704,78,0.97 [0.81-1.16],0.7235457444416162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21233,77,1.21 [0.87-1.69],0.2564640805080784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",21135,76,1.11 [0.91-1.34],0.2935053247048507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20626,75,1.03 [0.74-1.45],0.8445103605225042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20704,78,1.12 [0.69-1.81],0.6448169722136856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,24383,84,1.11 [0.79-1.56],0.5524690746480935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,20687,81,1.23 [0.98-1.55],0.0748988334682367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24552,86,1.29 [0.98-1.70],0.0652558571803905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24840,86,1.07 [0.89-1.30],0.4637818116452533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21257,77,0.97 [0.70-1.35],0.8534408922590738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,20626,75,1.32 [0.88-1.97],0.1743444927090106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,24096,86,0.98 [0.51-1.87],0.9439556860634196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,21257,77,1.04 [0.81-1.34],0.7510847524368728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,20634,75,0.96 [0.74-1.26],0.7808858611614067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,21290,77,0.99 [0.52-1.88],0.97234007317572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,24420,84,0.97 [0.68-1.39],0.881439080166689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,20626,75,1.28 [0.78-2.12],0.331175950974868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,24096,86,1.09 [0.74-1.62],0.6555756587591866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,19673,69,0.87 [0.56-1.38],0.5613292185477547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,24837,89,2.89 [0.97-8.61],0.0571227502776682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,24519,84,1.29 [1.00-1.65],0.0460352372545308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,24776,86,1.32 [1.00-1.75],0.05164115905494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,20704,78,0.95 [0.66-1.38],0.8050344044498827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,21174,77,0.99 [0.67-1.48],0.9715257548220158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20626,75,1.90 [1.02-3.53],0.0438969052110113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,20626,75,0.82 [0.45-1.49],0.5138223706531079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24837,89,1.43 [0.71-2.87],0.3200166810103356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24639,90,1.45 [0.89-2.36],0.139690887308202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20704,78,1.14 [0.62-2.10],0.6685280329996153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23823,88,0.99 [0.80-1.24],0.9580707352463697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,21174,77,1.01 [0.67-1.51],0.97953863611592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23956,85,0.76 [0.49-1.18],0.2168504706368971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,24111,86,1.23 [0.50-3.04],0.6585920867106206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24111,86,1.40 [0.66-2.97],0.3839584058761793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,20704,78,0.91 [0.63-1.33],0.637253964425001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,20687,81,1.55 [0.98-2.44],0.0588198072606948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,20705,76,0.99 [0.70-1.39],0.9502263945322544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,24522,89,1.02 [0.84-1.24],0.8692436993879024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,21174,77,0.50 [0.23-1.09],0.081651540527474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,24587,89,0.69 [0.40-1.19],0.1817148264341037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,23961,82,1.21 [0.95-1.54],0.1177807852187016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23663,82,1.02 [0.52-2.04],0.9454193659035444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,20813,78,0.61 [0.28-1.31],0.2035536557054586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24837,89,1.33 [0.62-2.85],0.4681664886338486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24335,83,0.92 [0.48-1.75],0.7901245857024511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,24111,86,0.95 [0.68-1.31],0.7331288078572497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,20890,76,0.65 [0.34-1.24],0.1939885210106526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,24530,85,1.18 [0.94-1.48],0.14729037192945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,20704,78,1.06 [0.79-1.41],0.7064861228148602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24727,86,0.86 [0.45-1.65],0.6593893140150444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,24592,89,0.55 [0.30-1.01],0.0535939405209506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,24422,88,1.32 [0.51-3.41],0.5665678811723106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,24592,89,0.57 [0.29-1.10],0.0920621617006215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,24420,84,1.10 [0.92-1.33],0.296555586765294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,20705,76,0.85 [0.61-1.19],0.344835828110752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,20537,77,1.30 [0.81-2.09],0.2748483244343559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,24335,83,1.10 [0.87-1.39],0.4321386509771594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,20890,76,1.36 [0.79-2.36],0.2681092188130471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,20687,81,1.64 [1.04-2.59],0.0324199086797221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21174,77,0.98 [0.55-1.74],0.949209076873194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,20813,78,1.11 [0.93-1.33],0.2606637978932363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,24386,84,1.59 [0.77-3.28],0.2137190971401468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20626,75,1.49 [1.07-2.07],0.0178574209986416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,24837,89,1.26 [0.71-2.24],0.4315973389646196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,24518,89,1.16 [0.67-2.01],0.5993094752335747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,20537,77,0.85 [0.54-1.35],0.5032482383710022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,20687,81,0.93 [0.63-1.37],0.7233142128976306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,21233,77,0.95 [0.73-1.24],0.7192285751827145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,20537,77,0.82 [0.44-1.52],0.5238491683173886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,20687,81,1.15 [0.92-1.45],0.2194952508403732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,20890,76,1.09 [0.57-2.08],0.8048782631344286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,20626,75,1.33 [1.03-1.73],0.0309069777611584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,20626,75,1.11 [0.72-1.70],0.6360821815545441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24776,86,1.42 [0.67-3.04],0.3642184471189236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,21298,80,1.26 [0.62-2.56],0.5196971642251438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,21011,81,1.08 [0.58-2.01],0.8155305647714987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,24534,88,1.13 [0.82-1.57],0.4493961034828965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,21319,81,0.83 [0.50-1.37],0.4655828982837269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,21209,81,0.99 [0.44-2.23],0.9782283807857416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,21319,81,1.21 [0.29-4.96],0.7927078433759306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,24603,89,1.18 [0.86-1.62],0.2921454885079174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,24604,86,0.69 [0.33-1.44],0.3238956757919219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,24562,90,1.03 [0.55-1.93],0.9270797083283816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,24573,90,1.88 [0.68-5.22],0.2255700522847441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",24518,89,0.92 [0.75-1.13],0.4193440344532065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",24552,86,1.00 [0.78-1.27],0.9814753693834048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",21290,77,1.19 [0.81-1.77],0.375266095848788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",24837,89,1.11 [0.76-1.62],0.6020785800556142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,24709,86,1.14 [0.87-1.50],0.3352716245823487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,24078,86,0.83 [0.58-1.20],0.3288989490158125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,24530,85,0.94 [0.67-1.34],0.747838734225923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,24552,86,1.21 [0.95-1.53],0.1262077817531314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,21197,76,0.96 [0.69-1.32],0.7849634273628212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,21257,77,1.00 [0.86-1.14],0.9451039285565884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,21174,77,1.07 [0.50-2.28],0.8641913284977926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,20704,78,1.04 [0.73-1.47],0.8312361783469531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,21290,77,1.06 [0.49-2.29],0.8886243214959663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,24420,84,1.02 [0.58-1.78],0.9466198827835876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,24524,86,1.45 [0.76-2.78],0.2600404274739458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,21197,76,1.13 [0.88-1.47],0.3358226978584334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,24837,89,0.76 [0.38-1.51],0.4283558358003079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,20705,76,1.04 [0.76-1.42],0.8280447287948712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,24747,89,1.29 [0.81-2.06],0.2782972923283562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,24840,86,1.21 [0.73-2.01],0.4579837628232112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,21283,78,1.13 [0.55-2.32],0.7474604305294479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,20705,76,1.20 [0.85-1.69],0.3024470052325698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",24552,86,0.92 [0.71-1.20],0.537148439274774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21290,77,0.82 [0.60-1.12],0.204463926190283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,24530,85,0.96 [0.64-1.44],0.8317455823327335
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21257,77,1.16 [0.47-2.83],0.7453753897831549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24534,88,1.49 [1.04-2.14],0.0316502526493934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24408,90,1.19 [0.84-1.68],0.3338403855505449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23956,85,0.75 [0.54-1.06],0.106404500282988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24522,90,0.74 [0.52-1.06],0.0972665752297072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,21264,80,0.85 [0.60-1.20],0.3631401877965775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,24402,88,1.38 [0.84-2.26],0.2037074786132036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24552,86,1.26 [0.81-1.94],0.3040018992362234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24733,86,0.87 [0.57-1.32],0.5071019648534838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24096,86,1.67 [1.20-2.34],0.0026934813972576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24534,88,0.95 [0.68-1.33],0.7543296242647408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,24530,85,0.85 [0.64-1.13],0.2726506481198039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23956,85,0.69 [0.47-1.02],0.0613213941046175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",20626,75,0.82 [0.55-1.21],0.3143348476276059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",20626,75,0.94 [0.62-1.43],0.7836357118343734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,23956,85,0.93 [0.69-1.27],0.6562370881092858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,23956,85,1.03 [0.69-1.53],0.8952574902108188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,24573,90,1.19 [0.67-2.11],0.5614692480257096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,20822,79,1.29 [0.65-2.58],0.4642515338799918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21257,77,1.09 [0.84-1.42],0.5224362195958642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,20687,81,1.42 [1.10-1.82],0.006424505567018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,20687,81,0.96 [0.60-1.53],0.8658662286315472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,24639,90,1.21 [0.95-1.53],0.1216094030294754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,24530,85,0.99 [0.74-1.32],0.9431097883800272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,20687,81,1.23 [0.83-1.83],0.3019460022156857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,24728,86,0.96 [0.82-1.12],0.5762676047975853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,24722,86,1.10 [0.80-1.52],0.5583025090616272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,20687,81,0.95 [0.45-2.01],0.8981315519855769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,24096,86,1.47 [0.88-2.47],0.1419065592778979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,20687,81,1.16 [0.76-1.76],0.4980534691623368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,20537,77,0.81 [0.58-1.14],0.2235324519205803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,20494,77,1.33 [0.76-2.32],0.3151238865740057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,24592,89,0.62 [0.37-1.05],0.0776716451441565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,21283,78,0.92 [0.60-1.41],0.6899250346780205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,21233,77,1.54 [0.86-2.75],0.1437947738784449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,24592,89,0.58 [0.26-1.33],0.2009089284356637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,20813,78,0.99 [0.66-1.51],0.9786846150647672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,21298,80,1.01 [0.72-1.41],0.9632934253075868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,23961,82,0.85 [0.60-1.23],0.3924285181918414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",20634,75,0.98 [0.74-1.29],0.8740382984575349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,20626,75,0.99 [0.63-1.58],0.9823344102194562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,23961,82,1.13 [0.86-1.48],0.369125805340479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,24499,89,1.04 [0.82-1.32],0.7274171887381631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21257,77,0.98 [0.79-1.22],0.8627225162907577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24643,86,1.02 [0.87-1.21],0.7727522267229032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24383,84,1.42 [0.91-2.20],0.122298957051188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24383,84,1.04 [0.85-1.28],0.6976972908805321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23913,81,1.06 [0.70-1.58],0.7936432387102469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,21197,76,1.16 [0.81-1.65],0.4272277031854493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,23956,85,1.14 [0.96-1.35],0.1345308421894241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24383,84,1.21 [0.61-2.41],0.5799128705053089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,24379,84,0.55 [0.21-1.43],0.2184655027093988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,23956,85,1.05 [0.57-1.94],0.885809510459371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,24840,86,1.29 [0.74-2.28],0.3700349760366778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,24592,89,0.63 [0.38-1.05],0.0745364003054256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,23961,82,0.82 [0.58-1.16],0.2526392976580966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,23956,85,0.81 [0.46-1.40],0.4453760471534025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,21319,81,1.11 [0.51-2.45],0.7911447936946654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,21233,77,1.16 [0.72-1.85],0.54439918470507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21174,77,1.13 [0.63-2.02],0.6932867710384298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,20687,81,1.00 [0.82-1.22],0.9891138576247288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,24472,88,0.46 [0.26-0.83],0.0098635764366728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,24776,86,1.35 [0.70-2.59],0.3642550457488434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,24515,89,0.97 [0.87-1.08],0.5491284497972987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,20494,77,1.05 [0.57-1.93],0.8787244400045309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,23961,82,1.20 [0.79-1.83],0.3923070108842044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20687,81,1.47 [1.03-2.11],0.034093666773639
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,24530,85,1.06 [0.85-1.33],0.579423840191206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,23956,85,0.99 [0.82-1.21],0.9560833148223112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,20626,75,0.96 [0.70-1.33],0.8085220486174887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,20705,76,0.62 [0.33-1.17],0.1422975512532864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,24307,84,0.74 [0.36-1.51],0.4091242339680448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,20704,78,1.22 [0.86-1.73],0.2724416408237008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,24603,89,0.97 [0.67-1.40],0.8589384358118795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,20704,78,2.19 [0.88-5.46],0.0927102119318719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,24483,89,0.90 [0.47-1.72],0.7572439862350766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,21197,77,0.95 [0.73-1.23],0.677672240267341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,24667,88,0.94 [0.76-1.18],0.6141933600903537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,20813,78,0.74 [0.52-1.04],0.0825104605108974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,24592,89,1.27 [0.73-2.19],0.393298432323546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,23918,85,0.83 [0.51-1.38],0.4778403542570257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20854,75,1.10 [0.80-1.53],0.5513222919369531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24776,86,1.31 [0.86-2.00],0.2115475124686049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",24383,84,1.00 [0.72-1.40],0.998548199178053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",24760,86,1.08 [0.84-1.40],0.5568434011281005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,24096,86,1.15 [0.87-1.53],0.3360148302423093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,24496,88,1.14 [0.93-1.40],0.2151480397697439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,20705,76,0.63 [0.38-1.05],0.0739640559063028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,20634,75,1.17 [0.73-1.89],0.5159137445490933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,21174,77,1.07 [0.69-1.66],0.7606930349734463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20890,76,1.13 [0.85-1.51],0.4087058301484869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20634,75,0.94 [0.66-1.34],0.7484083555200185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,20537,77,1.30 [0.57-2.98],0.5370227302105544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,20687,81,1.03 [0.65-1.63],0.8969099467663482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20890,76,0.98 [0.62-1.54],0.915582553667875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20704,78,1.14 [0.77-1.70],0.5036461473728833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,20537,77,1.26 [0.96-1.66],0.0897722843861568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,24639,90,0.69 [0.52-0.93],0.0128641798144377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24420,84,1.51 [0.77-2.93],0.2296773940109372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24760,86,0.78 [0.37-1.63],0.5021088222495891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24096,86,0.87 [0.55-1.38],0.5474619140267148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21290,77,0.88 [0.39-1.97],0.7555850579546108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,24420,84,1.56 [0.62-3.96],0.3476384676014283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,20626,75,1.44 [0.90-2.31],0.1311859264634898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20369,77,0.98 [0.50-1.93],0.9637395841839476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,21257,77,1.15 [0.53-2.52],0.7207590148480136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,20890,76,1.01 [0.66-1.53],0.9693472925950668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,24660,89,1.10 [0.53-2.30],0.7996773858085137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,20626,75,1.03 [0.61-1.73],0.9174402530294062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,21233,77,1.19 [1.01-1.39],0.0322246744547002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20537,77,1.54 [0.68-3.46],0.2971191287116373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20704,78,1.07 [0.81-1.40],0.6461633022378531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,20705,76,0.87 [0.58-1.32],0.5179975674682166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21194,77,1.06 [0.75-1.48],0.7492219540964926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,24096,86,1.05 [0.76-1.44],0.7808171051861988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,23961,82,1.13 [0.77-1.66],0.539299252023929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,20626,75,1.42 [1.02-1.96],0.0360096483403732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,21319,81,0.67 [0.29-1.53],0.3412686515170061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,21233,77,0.99 [0.81-1.20],0.9003735457696878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,23956,85,1.17 [1.00-1.36],0.0445716423052951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20302,77,1.06 [0.70-1.62],0.7799553944468535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,20626,75,0.90 [0.54-1.51],0.6915463008050949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24420,84,0.84 [0.48-1.49],0.5571526585984069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,24837,89,1.39 [0.96-2.02],0.0832947639142764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,24552,86,0.78 [0.45-1.34],0.3647993951949465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,23961,82,0.75 [0.44-1.29],0.3034502612953951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,21290,77,1.01 [0.68-1.50],0.9520659387639184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,23921,84,1.35 [0.90-2.04],0.1480423514129887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,23956,85,1.06 [0.79-1.42],0.7079321989247189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23956,85,1.01 [0.87-1.17],0.9030481327869176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,24728,86,1.13 [0.56-2.31],0.7297168907000093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,24420,84,1.14 [0.44-2.90],0.7906513527280117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,24302,84,0.77 [0.38-1.57],0.4791039225886251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,20621,71,0.67 [0.46-0.98],0.0390620529728406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,23961,82,0.81 [0.59-1.13],0.2109624837279346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,21290,77,1.19 [0.88-1.59],0.2616141094816434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,21252,76,1.47 [0.99-2.19],0.0547412496183693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,24084,89,1.48 [0.89-2.45],0.1297991181782143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,24490,88,0.90 [0.61-1.32],0.5796979554750387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,24383,84,1.01 [0.43-2.38],0.976892817984709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,24524,86,0.95 [0.85-1.06],0.3187623443170975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,23956,85,1.02 [0.91-1.14],0.7825598490982981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,20813,78,1.01 [0.47-2.18],0.970362373432224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,23961,82,1.07 [0.77-1.49],0.6956978856640872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,24552,86,0.82 [0.65-1.04],0.1057640154053226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,21257,77,1.17 [0.64-2.14],0.6058661128051249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,21257,77,1.00 [0.76-1.32],0.991932677129474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,20813,78,1.00 [0.51-1.94],0.9951123662307004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,20537,77,0.93 [0.59-1.46],0.7590862856304007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,20704,78,1.34 [0.85-2.09],0.2047983229260504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,21233,77,0.69 [0.32-1.49],0.3416741202329556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,21197,76,0.97 [0.78-1.21],0.7862152979630114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,20687,81,1.43 [1.12-1.83],0.0039185981049696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,20687,81,1.15 [0.92-1.43],0.2143325612029932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,20537,77,1.06 [0.76-1.49],0.7226800901154649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,23495,80,0.92 [0.45-1.87],0.812895855027921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,20767,78,0.94 [0.53-1.66],0.8254438535553025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,24383,84,0.86 [0.55-1.36],0.5312402987001678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,20687,81,1.46 [0.94-2.29],0.0948007731528514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,24111,86,1.71 [1.25-2.33],0.0007527161865102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,24463,88,1.46 [0.86-2.46],0.1597190553750037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,20634,75,0.73 [0.37-1.44],0.367016660557777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,24398,84,1.16 [0.84-1.61],0.3680339557027571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20813,78,1.25 [0.99-1.58],0.0650371077815433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23961,82,1.14 [0.79-1.64],0.4905208808979153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,21174,77,0.96 [0.66-1.39],0.82463599245582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,20779,76,0.85 [0.45-1.62],0.6213958283534591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,21290,77,1.13 [0.84-1.53],0.4068444148760932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,24840,86,1.13 [0.76-1.66],0.5497640798196926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,20813,78,1.19 [0.86-1.63],0.2954498209898168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,21257,77,0.88 [0.68-1.15],0.3549088999036592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23956,85,1.04 [0.77-1.39],0.8110319126475509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20705,76,0.85 [0.52-1.38],0.509036313165815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,24534,88,1.11 [0.77-1.59],0.5877964828308819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,20704,78,1.70 [1.15-2.50],0.0077413702778997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,20813,78,1.24 [0.70-2.21],0.458811672660616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,21257,77,0.97 [0.73-1.29],0.847187639650406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,24776,86,1.72 [0.76-3.91],0.1921153395128418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24530,85,1.04 [0.86-1.26],0.6748916921895982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,21197,76,1.12 [0.71-1.76],0.6380752749839282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",21283,78,0.71 [0.43-1.20],0.2019391598835527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,24409,87,1.00 [0.56-1.79],0.9960701319063456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,20626,75,1.22 [0.88-1.69],0.2272095431977301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23795,84,0.96 [0.76-1.22],0.7460293244550724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,20813,78,0.99 [0.54-1.80],0.9681414788172872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,24496,88,1.13 [0.91-1.39],0.2685642929870164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,24420,84,1.01 [0.87-1.16],0.9109011991379627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,24760,86,0.79 [0.41-1.52],0.4809704517729531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,24383,84,1.07 [0.76-1.50],0.717276479817311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,21174,77,0.87 [0.57-1.33],0.5202941981158399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,21197,76,0.42 [0.20-0.88],0.0210019158720191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,21298,80,1.26 [0.83-1.91],0.277283609003121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21197,76,0.95 [0.71-1.28],0.7464134725453322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,23961,82,0.60 [0.27-1.34],0.211368288989281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,23891,81,1.50 [0.74-3.04],0.2608897229535558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,20634,75,1.09 [0.79-1.51],0.6081671376608371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,21257,77,0.52 [0.24-1.12],0.0966034859810116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,21197,76,1.14 [0.81-1.61],0.458224846201784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,24111,86,0.87 [0.65-1.18],0.371530767046577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,21174,77,0.83 [0.54-1.27],0.3900561191194232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,24552,86,1.11 [0.96-1.29],0.1547415711666574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21290,77,1.09 [0.78-1.53],0.6258072401747266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",21257,77,1.35 [0.88-2.09],0.1717009261878858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20634,75,1.32 [1.00-1.76],0.0501915894252881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,24111,86,1.13 [0.80-1.58],0.4841184280394867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24415,88,1.32 [0.62-2.81],0.473467612345665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,20704,78,1.14 [0.75-1.73],0.5416443654228922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",24420,84,0.95 [0.69-1.31],0.7600866097296757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,20420,77,1.14 [0.88-1.47],0.3135266813483003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,23956,85,1.06 [0.86-1.31],0.5761730563177956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,21212,80,0.98 [0.30-3.15],0.9668480903100798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",21177,80,0.74 [0.28-1.97],0.5456938414188225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,24517,86,0.96 [0.77-1.20],0.7246044166648453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,23956,85,0.83 [0.63-1.09],0.1747273149076668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,20626,75,1.02 [0.75-1.37],0.917339851942446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,23807,81,1.04 [0.78-1.37],0.8002028351976107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,21233,77,0.94 [0.86-1.03],0.1770575950182398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20890,76,0.93 [0.66-1.30],0.6626448989034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,20705,76,1.09 [0.84-1.43],0.5156517909754293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,24415,88,0.88 [0.48-1.59],0.660740690082336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,20890,76,0.97 [0.74-1.27],0.8177966158919772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,20626,75,1.32 [0.89-1.96],0.1722645670160163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,24626,89,0.98 [0.71-1.34],0.881744244002918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",24111,86,1.15 [0.94-1.40],0.1890287700433072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,24840,86,0.83 [0.47-1.47],0.5243042624142547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,24530,85,1.00 [0.75-1.34],0.9975162796581976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,24111,86,1.06 [0.84-1.35],0.6201284349555526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,20537,77,1.07 [0.70-1.62],0.7675536229042618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20626,75,1.15 [0.87-1.53],0.3366361713667283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24697,86,0.98 [0.75-1.27],0.8592091006649097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,24760,86,0.89 [0.77-1.04],0.1412971268955627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",24534,88,1.21 [0.95-1.54],0.1252554966048985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24729,86,1.33 [0.98-1.81],0.0637357004902089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24534,88,1.51 [0.89-2.59],0.1297586291918957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,24697,86,0.98 [0.76-1.26],0.8611355028662462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,24760,86,0.98 [0.72-1.34],0.9000238799548858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,21290,77,0.99 [0.81-1.22],0.9576530629027948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,20626,75,1.00 [0.66-1.53],0.9950560142698268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,24840,86,1.12 [0.79-1.57],0.5284430536631624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,20687,81,0.85 [0.56-1.28],0.428796434207233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,20634,75,0.85 [0.57-1.27],0.4227130502423534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,21197,76,0.98 [0.60-1.60],0.9295116511713268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,24730,86,1.02 [0.84-1.25],0.8286751698620174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21233,77,1.08 [0.78-1.49],0.6317203913083815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,24111,86,1.02 [0.73-1.44],0.8913448547567727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,20813,78,0.59 [0.26-1.33],0.203564137524686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,21233,77,0.94 [0.56-1.58],0.8257910317377899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,21290,77,1.26 [0.54-2.91],0.5939016851679193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,24530,85,1.11 [0.88-1.40],0.3965998255929061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,24840,86,1.24 [0.72-2.13],0.4460910129933378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,21101,80,0.82 [0.38-1.77],0.6095237875209583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23956,85,1.12 [0.88-1.43],0.338944287723428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,21233,77,1.07 [0.81-1.41],0.6201329169917915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,20687,81,1.08 [0.82-1.43],0.5789969195716873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,20626,75,1.10 [0.61-1.98],0.7414201893635788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,21199,77,1.06 [0.68-1.66],0.7934762709457769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,21257,77,0.62 [0.36-1.10],0.1007330440681314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,24111,86,1.31 [0.67-2.57],0.4379728747805543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21257,77,0.89 [0.46-1.73],0.7267031652818898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24447,85,0.82 [0.48-1.41],0.4695647972945941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24530,85,1.38 [0.71-2.71],0.3413798372877083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,24760,86,0.87 [0.56-1.35],0.53256514515899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,20771,78,1.03 [0.70-1.51],0.8747362199671496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20704,78,1.32 [0.91-1.93],0.1428251914017176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20626,75,1.20 [0.76-1.90],0.4271816532027036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,20501,77,1.14 [0.76-1.72],0.5144762780999397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,24276,85,0.64 [0.42-0.97],0.0347089857395648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23961,82,0.82 [0.53-1.28],0.3848289004521722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,20705,76,1.09 [0.83-1.42],0.5488044150689475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,24260,83,0.88 [0.58-1.34],0.5518121270192888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,24023,84,1.33 [1.06-1.68],0.0136539213037094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21257,77,1.17 [0.79-1.73],0.4352977269478914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,24840,86,1.05 [0.81-1.35],0.716722281016577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,23956,85,1.01 [0.60-1.70],0.9762893070543586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,21002,76,1.21 [0.96-1.53],0.1119947025113964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,20861,76,0.96 [0.75-1.22],0.7224964790978711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20704,78,1.58 [0.96-2.59],0.0701765652023308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,21209,81,0.95 [0.48-1.87],0.8852979896814179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,20704,78,1.13 [0.89-1.43],0.3034913324750089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24420,84,1.01 [0.60-1.68],0.9773231171329478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24760,86,1.01 [0.58-1.77],0.97150957453567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20687,81,1.30 [0.71-2.41],0.3946833152964248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,20704,78,1.04 [0.83-1.30],0.7373808010364966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24530,85,1.01 [0.63-1.64],0.9596517661984164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21233,77,0.82 [0.58-1.17],0.2693442045977365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,20626,75,1.56 [1.10-2.19],0.0117556905331652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20704,78,0.82 [0.51-1.31],0.4068959986901257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,23856,81,0.96 [0.71-1.31],0.815015309205146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,24587,89,1.16 [0.91-1.49],0.2312185222326568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,21174,77,1.33 [0.77-2.30],0.3128015478133475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,24134,85,0.97 [0.74-1.28],0.8495150277294782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,24760,86,0.62 [0.36-1.06],0.0824763546035275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,24327,90,1.16 [0.55-2.43],0.7022277219179727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,20634,75,1.18 [0.93-1.49],0.1804417773471441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,20634,75,1.00 [0.60-1.68],0.9906975582422493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",24592,89,0.99 [0.74-1.34],0.9718367213161216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,24364,89,1.06 [0.47-2.38],0.8836284155568338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,24837,89,0.93 [0.39-2.19],0.8608165018551865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,24096,86,1.10 [0.87-1.39],0.4238416115502678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24410,88,0.72 [0.37-1.39],0.3301462747693166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,24837,89,0.80 [0.45-1.43],0.4567015528925848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24837,89,0.82 [0.39-1.74],0.6122784517602602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,24530,85,0.95 [0.67-1.36],0.79252781331786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,24552,86,1.24 [0.81-1.90],0.3251834770781268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,24420,84,0.85 [0.31-2.33],0.7445204554659495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,20890,76,1.16 [0.75-1.77],0.5066315687128775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,23961,82,0.90 [0.58-1.39],0.6440139783008967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",20704,78,0.96 [0.68-1.36],0.826449307566141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,24840,86,2.18 [0.27-17.43],0.4613009793040836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,24760,86,1.14 [0.75-1.72],0.544271562314064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20716,73,1.12 [0.64-1.96],0.6849306485436112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20890,76,1.23 [0.83-1.83],0.3004234739625154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20890,76,1.51 [0.93-2.44],0.0949080876939448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,21197,76,0.50 [0.23-1.08],0.0781074114617633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,24096,86,0.97 [0.83-1.15],0.7454209877256194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,24639,90,0.64 [0.25-1.64],0.3547453777214913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,24383,84,0.90 [0.61-1.31],0.5773051875166109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,23961,82,1.41 [0.95-2.10],0.0898232872262079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,20634,75,0.67 [0.41-1.09],0.1070674583358101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24530,85,0.84 [0.48-1.48],0.5458560711187753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,20626,75,1.01 [0.54-1.90],0.9706654510691302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,20705,76,0.66 [0.38-1.15],0.1400265011306501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,21257,77,1.08 [0.76-1.53],0.6851951960538548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20634,75,1.32 [0.95-1.82],0.0945528536921422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21283,78,0.71 [0.32-1.56],0.3931784499818075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,24420,84,0.71 [0.28-1.80],0.4705294970629348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20626,75,1.02 [0.64-1.62],0.937237497784452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,24534,88,1.00 [0.45-2.21],0.9980900125899016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,24795,89,1.01 [0.87-1.17],0.9195437589993092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,24790,89,1.23 [0.90-1.67],0.1931401815994805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,24602,90,1.43 [0.72-2.82],0.3082058408163891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24211,85,1.17 [0.72-1.91],0.5287252812731841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,24413,90,1.16 [0.61-2.22],0.643451517785619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,24837,89,1.42 [0.82-2.46],0.2160069022753013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24552,86,0.94 [0.53-1.69],0.8465918162783124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,20687,81,1.04 [0.80-1.36],0.7501869505276465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,20626,75,0.98 [0.67-1.44],0.920969155959781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,21288,81,1.06 [0.48-2.34],0.8795105144626685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,20537,77,1.09 [0.89-1.34],0.4213996354706374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,20704,78,1.07 [0.63-1.81],0.7996517835070416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,24420,84,1.07 [0.60-1.90],0.8197032661745525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,24552,86,1.39 [0.75-2.56],0.2922415687666481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,21290,77,0.99 [0.76-1.29],0.9550863508900675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,24530,85,0.99 [0.81-1.23],0.9557320400762012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,23956,85,1.01 [0.82-1.24],0.906067556683044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24096,86,0.98 [0.77-1.25],0.8768052559887599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,24096,86,0.93 [0.65-1.33],0.700205110768956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24639,90,0.76 [0.39-1.50],0.4306981299282497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,24096,86,0.97 [0.71-1.32],0.8404126462723327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24420,84,0.98 [0.76-1.28],0.9036060544079402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24840,86,1.00 [0.70-1.42],0.9840583491194758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24096,86,1.05 [0.63-1.77],0.8479760996470281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,20687,81,1.03 [0.63-1.70],0.8951420335403506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,24096,86,1.18 [0.88-1.59],0.2762007237273132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,24202,88,0.70 [0.33-1.46],0.3355502145370929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,20634,75,0.98 [0.45-2.10],0.9511082439774552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,24530,85,1.02 [0.56-1.84],0.9554757938821988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24096,86,1.34 [0.76-2.37],0.3041365651670158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,24840,86,0.79 [0.49-1.26],0.3152139154090871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,24053,86,0.97 [0.62-1.51],0.8922881646860359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,24096,86,0.94 [0.70-1.25],0.6559240664596693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,24096,86,1.58 [1.08-2.32],0.0188168782496179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,24096,86,1.15 [0.93-1.42],0.1883216663533141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,24534,88,1.11 [0.72-1.72],0.6256190782671234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,24211,82,1.13 [0.79-1.63],0.4990591579347685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,24426,88,0.92 [0.61-1.41],0.7130967401399468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24602,90,0.96 [0.51-1.80],0.8902015662115033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,24840,86,0.94 [0.53-1.69],0.8447478630071468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,24226,82,1.00 [0.89-1.12],0.9974913621143788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,23945,85,0.80 [0.59-1.07],0.1341279811286197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,24096,86,1.29 [1.01-1.65],0.0449472940573203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,23979,86,1.08 [0.78-1.50],0.6347981903848469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,24490,88,0.67 [0.28-1.58],0.3569671567991621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,24478,89,0.66 [0.25-1.72],0.3947963567241859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,24534,88,1.07 [0.71-1.63],0.7419575932948266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,24747,89,0.86 [0.58-1.27],0.4537985424041808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,24096,86,0.78 [0.49-1.26],0.3143243748668387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,24462,89,0.72 [0.49-1.07],0.1029803855674581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,24096,86,0.54 [0.30-0.99],0.045462938168893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,24096,86,0.98 [0.67-1.44],0.9250295748412136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,24096,86,1.24 [0.87-1.77],0.2357987703423151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,20687,81,1.14 [0.70-1.84],0.6069356192350228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,20687,81,1.20 [0.86-1.68],0.2864663461951329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,21174,77,1.12 [0.82-1.53],0.4624648277601947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,24096,86,1.09 [0.72-1.66],0.671630942061987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,24096,86,1.06 [0.72-1.58],0.7536574439518298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,20461,77,0.77 [0.41-1.46],0.4260904335966399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24375,88,1.47 [0.94-2.31],0.0940555936590456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,24096,86,1.14 [0.71-1.84],0.5910213995366115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,21174,77,0.92 [0.49-1.72],0.7970226597225142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,20537,77,1.22 [0.83-1.79],0.3230417715397002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,20687,81,1.17 [0.85-1.61],0.332687162212979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,20617,81,0.89 [0.52-1.53],0.6816542902385412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,24530,85,0.82 [0.51-1.31],0.4056291483922003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,24096,86,0.95 [0.58-1.55],0.8308171138658333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,23923,81,0.46 [0.28-0.75],0.0022528024938232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,20687,81,1.18 [0.88-1.60],0.2713976631405426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,20622,81,0.80 [0.55-1.15],0.2269350929544219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,24096,86,1.14 [0.63-2.06],0.669822831808454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,24096,86,1.09 [0.86-1.37],0.4798641686174155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24530,85,0.74 [0.42-1.29],0.2890781731705332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,24096,86,0.95 [0.82-1.09],0.4533013188703162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,24530,85,0.79 [0.55-1.13],0.1934996965055073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,24420,84,1.02 [0.78-1.32],0.9029458631118432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,24362,87,0.86 [0.50-1.49],0.5970078058823212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,24552,86,0.72 [0.24-2.18],0.5615740091841266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,24530,85,1.08 [0.81-1.45],0.6047543776888445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,24534,88,0.79 [0.56-1.11],0.171225828963931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,20890,76,0.81 [0.50-1.30],0.3793097651298877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23926,82,0.96 [0.69-1.36],0.8307250141934377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,21174,77,0.50 [0.28-0.90],0.0211582335222005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,24383,84,1.11 [0.81-1.52],0.5050681909746637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,21233,77,1.32 [0.90-1.93],0.1613277502028702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,20634,75,0.51 [0.21-1.23],0.1323894073459084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,23913,81,1.09 [0.73-1.61],0.6814017339500769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,20813,78,1.02 [0.66-1.57],0.9358200822257652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,24534,88,1.00 [0.64-1.57],0.9857636568320592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,24420,84,1.03 [0.73-1.46],0.8460581572257478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20704,78,0.98 [0.68-1.42],0.9150272357451577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21257,77,0.84 [0.48-1.49],0.5524763675596618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24420,84,1.08 [0.89-1.32],0.4405521829619963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,21233,77,1.16 [0.87-1.55],0.312408696553156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,21174,77,0.62 [0.35-1.12],0.1114392085134629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,21197,76,0.96 [0.76-1.20],0.698792698449127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,20687,81,1.10 [0.31-3.96],0.8839839544455357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,24342,84,1.10 [0.89-1.36],0.3866889915355509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24420,84,0.99 [0.70-1.41],0.9571603861261962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24111,86,1.01 [0.81-1.25],0.9435104266775748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,24096,86,1.07 [0.81-1.40],0.6418472954223443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,24530,85,1.09 [0.90-1.31],0.370170879448145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23594,81,1.01 [0.60-1.71],0.958214613073406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,24530,85,0.94 [0.58-1.54],0.8177382101183421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,21283,78,1.17 [0.75-1.82],0.4954367916063534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,21046,76,1.04 [0.83-1.30],0.7245916477342923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,24530,85,1.01 [0.57-1.77],0.9854855509046304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,20813,78,1.27 [0.66-2.43],0.4725174019163775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,24534,88,1.02 [0.47-2.18],0.965050519157566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,24530,85,1.10 [0.78-1.55],0.5939812024350594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,20687,81,0.96 [0.59-1.58],0.8870968974191498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,24534,88,0.90 [0.49-1.64],0.7258773352911987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,24760,86,0.82 [0.26-2.56],0.7266624954013926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,20890,76,0.90 [0.58-1.41],0.6424527042080929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,24480,90,0.89 [0.37-2.12],0.7946137980560816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,23956,85,1.63 [1.05-2.54],0.0308855600814328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,24111,86,1.22 [1.02-1.45],0.0280923231676092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,24386,88,1.08 [0.56-2.10],0.8096408848853306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,24592,89,0.88 [0.54-1.44],0.6145057437521466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,24096,86,0.89 [0.47-1.71],0.7306562004392957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,24760,86,1.05 [0.70-1.58],0.802927005840778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,21283,78,1.31 [0.72-2.37],0.3761926412415863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21319,81,1.85 [0.71-4.80],0.2077534061882446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24602,90,0.86 [0.53-1.39],0.5445875671454888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21319,81,1.35 [0.63-2.91],0.4431050121885743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21174,77,0.85 [0.51-1.44],0.5551246128450393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,24530,85,0.98 [0.71-1.35],0.9136419533815112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,20626,75,1.22 [0.89-1.67],0.2192445692303034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20704,78,0.90 [0.65-1.25],0.5442498298471332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20634,75,0.73 [0.42-1.27],0.263418737762545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23961,82,0.99 [0.66-1.47],0.9427822316795016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,20537,77,0.87 [0.53-1.42],0.5710224208217312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,24776,86,1.64 [0.78-3.41],0.1899485853211081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,20813,78,1.54 [1.06-2.25],0.0232710553874407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,24096,86,0.98 [0.71-1.34],0.8796381877494064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20537,77,0.83 [0.54-1.27],0.3868503880543023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,21197,76,1.06 [0.83-1.36],0.6319877393783446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,24096,86,1.09 [0.78-1.54],0.612425419550672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24420,84,1.10 [0.71-1.71],0.6708314652011638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,21197,76,0.97 [0.79-1.19],0.7564490877398631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,20634,75,1.02 [0.69-1.52],0.9071768669869438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,20705,76,1.02 [0.77-1.37],0.8745270426061821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,23961,82,1.00 [0.68-1.45],0.9825837568175048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20817,76,1.08 [0.68-1.70],0.744424686727127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,20687,81,0.98 [0.77-1.24],0.8578412161813773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,24592,89,0.48 [0.28-0.81],0.0067303403399337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,23961,82,0.73 [0.42-1.26],0.2627426096288079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,20537,77,0.92 [0.64-1.32],0.6488031421173188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,20704,78,0.91 [0.64-1.27],0.5687546337348179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,21233,77,1.54 [0.84-2.82],0.161661995027089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,20890,76,1.07 [0.79-1.45],0.6654033566316114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,20890,76,0.65 [0.28-1.47],0.2977633744321907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,21174,77,1.11 [0.78-1.57],0.5588756527345667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,20626,75,1.07 [0.61-1.85],0.8215525409360699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,20634,75,1.08 [0.82-1.42],0.5886866322301446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,20626,75,1.02 [0.85-1.22],0.840645601773562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,24420,84,1.13 [0.89-1.43],0.3121849156290837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21174,77,1.05 [0.81-1.36],0.6968667607654602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23956,85,0.86 [0.66-1.12],0.2719057513042929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21197,76,0.97 [0.85-1.10],0.640959909193908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23956,85,0.95 [0.81-1.11],0.537156745432578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20537,77,0.87 [0.64-1.19],0.3834267336366022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,20634,75,0.83 [0.53-1.30],0.4230572832729445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,23961,82,1.00 [0.60-1.67],0.9924046811820786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,24573,90,1.70 [0.91-3.19],0.0969938076886999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,24552,86,0.93 [0.56-1.54],0.774220146089012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,23961,82,1.05 [0.80-1.37],0.7260936420951845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,20634,75,1.06 [0.62-1.78],0.8407170277531666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,21257,77,1.13 [0.77-1.66],0.5362069090983187
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,24289,89,0.92 [0.79-1.08],0.3002496716935917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,24518,88,0.73 [0.46-1.17],0.1934469525806604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,24341,87,0.65 [0.34-1.23],0.1855079510693597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,23956,85,1.05 [0.91-1.21],0.4844066698126319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,23968,84,1.41 [0.91-2.19],0.122529992727357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,24760,86,0.88 [0.58-1.33],0.5323187873211958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,21141,77,1.02 [0.67-1.56],0.9321560476335704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,21283,78,1.02 [0.79-1.32],0.877560821166011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,24760,86,1.12 [0.82-1.53],0.4721646436990336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,24556,88,0.53 [0.31-0.88],0.0154017086687941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,20267,77,1.36 [0.81-2.29],0.2505649147527822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,23686,82,0.93 [0.53-1.63],0.7961745046637242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,20917,81,0.78 [0.33-1.82],0.5622793685932822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24840,86,1.03 [0.61-1.74],0.909376455468071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20634,75,0.88 [0.59-1.33],0.5547702004799361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,24840,86,0.83 [0.55-1.27],0.3952361238804465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,20687,81,1.28 [0.84-1.96],0.2435262127541619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,21233,77,0.82 [0.52-1.30],0.4018057354523581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",23207,81,1.15 [0.61-2.16],0.665975343113731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",20626,75,1.40 [0.87-2.23],0.1633249163343767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",24420,84,1.02 [0.80-1.29],0.8961541317218642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",24501,85,1.33 [1.02-1.74],0.0374565423918863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",23961,82,0.69 [0.46-1.05],0.082984320765395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",20626,75,1.15 [0.70-1.88],0.583572197552278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",20634,75,0.90 [0.60-1.34],0.5943161667102868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,24502,86,1.34 [0.98-1.85],0.069737794600297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,24840,86,0.93 [0.61-1.42],0.7462823875536554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,24592,89,0.97 [0.51-1.84],0.9167456003747524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21290,77,1.00 [0.78-1.28],0.99707056449005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,21137,77,0.74 [0.43-1.26],0.2608267567182927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,24552,86,1.33 [1.01-1.75],0.0440089460852657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24420,84,0.89 [0.54-1.46],0.6381532304706465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24518,89,1.05 [0.60-1.81],0.8743015533134253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24383,84,1.00 [0.83-1.20],0.9619091570276836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,20626,75,0.76 [0.45-1.26],0.2853237132087855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,24639,90,1.25 [0.73-2.13],0.4194161219632208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,20704,78,0.69 [0.34-1.39],0.3006019162200151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,20708,76,0.99 [0.44-2.24],0.981763726404548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,23801,83,1.89 [0.68-5.20],0.2203058245354954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,24792,86,0.94 [0.66-1.35],0.7519844341364701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,21174,77,0.69 [0.38-1.25],0.2190364911903977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,24096,86,1.09 [0.74-1.62],0.6663314026083365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,21174,77,1.06 [0.77-1.46],0.7195000784820723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,24840,86,1.13 [0.88-1.46],0.3394471739614632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,24420,84,1.10 [0.94-1.28],0.222031815273966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,20687,81,1.32 [1.04-1.68],0.0222225858749671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24335,83,1.09 [0.59-2.02],0.7800509411547786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,24602,90,1.34 [0.99-1.81],0.0588362913750447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,24776,86,1.11 [0.87-1.42],0.40728498724738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,21298,80,0.70 [0.27-1.86],0.4791163568004433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,21257,77,0.95 [0.66-1.37],0.7936791818140869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,23761,87,0.75 [0.44-1.28],0.2945678674166194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,21283,78,0.86 [0.54-1.36],0.5123798492682916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,24601,89,0.86 [0.60-1.24],0.419599424320876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,21257,77,1.13 [0.91-1.41],0.2560546066949621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,21290,77,0.93 [0.66-1.31],0.6774688594494314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,24728,86,0.86 [0.60-1.24],0.4239137262788762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,20071,76,1.00 [0.72-1.38],0.9815153756032444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,20634,75,0.99 [0.72-1.35],0.9364724235196148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,21257,77,1.31 [0.72-2.39],0.3779676032060699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,24552,86,0.98 [0.74-1.29],0.8724898399578885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,24552,86,0.81 [0.43-1.51],0.4991158248076555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,21257,77,1.07 [0.72-1.60],0.7368762830745024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,24552,86,1.46 [0.85-2.48],0.1670323160369391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,24598,89,1.67 [0.92-3.02],0.0925494238935894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,21319,81,0.75 [0.35-1.59],0.4493973493255299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,24518,89,1.11 [0.79-1.57],0.5555735008435763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,24506,86,0.81 [0.50-1.32],0.4035647628107883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,24776,86,1.27 [0.94-1.71],0.1183286407086832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24515,89,1.12 [0.62-2.05],0.7047123636986221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,24639,90,1.21 [0.74-1.99],0.4498707093600855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,23956,85,1.17 [0.98-1.41],0.0831731082447057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24550,89,1.15 [0.84-1.56],0.3862024587139123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,23961,82,0.93 [0.63-1.39],0.7402986550747126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,24530,85,0.76 [0.34-1.72],0.5138823496900854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24534,88,0.82 [0.49-1.39],0.4671556494483871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21283,78,1.31 [0.99-1.72],0.0561223151591981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20626,75,0.95 [0.61-1.48],0.8294176959333474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24524,86,1.37 [0.76-2.48],0.3007081067833248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21290,77,1.20 [0.89-1.62],0.2401973702589348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24837,89,1.53 [0.77-3.02],0.224935024000498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24700,89,0.94 [0.55-1.61],0.8294913030448356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24096,86,1.07 [0.68-1.70],0.7614128195169337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24837,89,1.01 [0.77-1.31],0.9544239392948785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,20704,78,0.99 [0.68-1.44],0.97486546491239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,21152,76,1.11 [0.81-1.52],0.5228108304825906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21233,77,1.66 [0.82-3.36],0.1574985287220103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,21257,77,1.09 [0.59-2.02],0.7811483104656407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,20634,75,0.92 [0.63-1.33],0.6533277096216896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",20704,78,1.02 [0.80-1.31],0.855737516095741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),20804,79,1.06 [0.94-1.19],0.3679367465467249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24420,84,0.94 [0.59-1.49],0.7828510670498887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,24552,86,1.13 [0.75-1.69],0.5517113175634515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,23764,80,0.85 [0.61-1.20],0.3572433972638333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,20626,75,1.10 [0.79-1.52],0.5732721833996264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20626,75,1.06 [0.77-1.44],0.7352309907896644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20705,76,1.03 [0.66-1.61],0.8887598190350251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,21319,81,1.35 [0.60-3.00],0.4677662394986059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24697,86,1.39 [0.80-2.40],0.2421192222353693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20615,80,1.34 [0.69-2.62],0.3893016633591402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,24420,84,1.00 [0.49-2.06],0.9947835029952502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,24552,86,1.08 [0.63-1.86],0.7769917360384814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,20705,76,0.66 [0.34-1.30],0.230229059983673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,20705,76,0.87 [0.63-1.19],0.3820152866638834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24776,86,1.08 [0.79-1.49],0.6277715672596775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,24420,84,0.92 [0.56-1.53],0.7467491893456717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21197,76,1.28 [0.77-2.13],0.3348254197699726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,20705,76,0.93 [0.58-1.50],0.7647529799243991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,21290,77,1.09 [0.70-1.70],0.7146216987146783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21174,77,0.88 [0.56-1.38],0.5779852501391183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,24096,86,0.66 [0.40-1.07],0.089119003957979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20705,76,0.88 [0.50-1.54],0.6528201085307572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21257,77,0.64 [0.26-1.54],0.3143898533049509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,23956,85,1.04 [0.75-1.45],0.806012551482816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,20890,76,1.10 [0.87-1.38],0.4322515365690395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,24530,85,1.04 [0.66-1.66],0.854524223899559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24530,85,1.05 [0.65-1.72],0.8319387047405475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,24760,86,1.00 [0.73-1.36],0.9794564064060792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,21174,77,1.26 [0.73-2.19],0.4039448653034574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,24837,89,1.51 [0.83-2.77],0.1783496434313737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,23956,85,0.95 [0.65-1.38],0.772906521113909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24378,88,0.96 [0.47-1.96],0.920529956795744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,24096,86,0.90 [0.56-1.46],0.6776369371284825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,21174,77,0.81 [0.48-1.38],0.440784079050708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,24266,84,0.89 [0.66-1.20],0.435930307426256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,24378,89,1.01 [0.60-1.69],0.9837293832959868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,24530,85,1.18 [0.71-1.96],0.5295984773056931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24304,85,0.96 [0.49-1.88],0.9010667222421148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,24383,84,0.81 [0.46-1.41],0.450672227661439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,23956,85,0.90 [0.61-1.33],0.5903298296075369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,24420,84,1.19 [0.95-1.49],0.1357483112559433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,23961,82,1.09 [0.83-1.43],0.5238952913947541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,24406,88,0.75 [0.43-1.31],0.3155674383891087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,23956,85,0.92 [0.62-1.38],0.6945272921968626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,20634,75,0.86 [0.67-1.10],0.2344073287090364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20705,76,1.03 [0.83-1.27],0.8132289819030738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21319,81,1.51 [0.51-4.51],0.4604831341923445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,20537,77,0.71 [0.37-1.38],0.3176119344716309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,20813,78,1.32 [0.99-1.77],0.0574198379752673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,20704,78,1.24 [0.78-1.97],0.357828463962664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24304,83,1.13 [0.80-1.59],0.4940662061102346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,23956,85,0.91 [0.55-1.52],0.723125582523086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,20705,76,0.85 [0.53-1.36],0.4936407275169173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,20890,76,0.95 [0.73-1.23],0.6949619775011919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,23956,85,1.17 [0.79-1.72],0.4348328333786988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,21290,77,1.74 [0.92-3.28],0.088700285301512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,21174,77,1.00 [0.68-1.47],0.9926834920084784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20704,78,0.98 [0.42-2.28],0.9665175102980664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,21290,77,0.89 [0.62-1.28],0.5300745077171348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20537,77,0.54 [0.35-0.84],0.005935054971614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,24639,90,1.06 [0.91-1.24],0.4361253185338016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,24592,89,0.56 [0.29-1.08],0.082825230245237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,20626,75,1.04 [0.74-1.46],0.8436679121877634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20634,75,1.48 [0.76-2.88],0.2533960133313109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20626,75,0.99 [0.69-1.41],0.9408571326689512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,21233,77,1.09 [0.70-1.71],0.6970206646088899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21197,76,1.19 [0.85-1.65],0.3092928304764055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24530,85,1.02 [0.85-1.24],0.807511606766566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23956,85,1.00 [0.82-1.21],0.987316796258811
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,24335,83,1.08 [0.91-1.28],0.3973028041757718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,20537,77,1.15 [0.75-1.76],0.5332367018490048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,24530,85,0.92 [0.60-1.42],0.7119328349346006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,20890,76,1.04 [0.78-1.40],0.7770231656796147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,20537,77,0.93 [0.78-1.10],0.4043999737766737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,23961,82,1.04 [0.71-1.53],0.8383404274911098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,24552,86,1.00 [0.48-2.09],0.9984629106327328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",20767,78,1.11 [0.86-1.42],0.4286085994799973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,24335,83,1.22 [0.53-2.82],0.6461876547060813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,24562,89,1.25 [0.66-2.36],0.4875379391034881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,24342,84,0.82 [0.44-1.52],0.521357422419314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,23956,85,1.11 [0.91-1.37],0.2996163912251022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,23961,82,1.17 [0.98-1.41],0.0907717149800091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,24837,89,1.08 [0.77-1.52],0.6454959190821277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,21019,80,1.13 [0.92-1.39],0.230135815510742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,24602,90,0.76 [0.43-1.35],0.3486859319719585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21257,77,1.21 [0.78-1.88],0.3892363643682653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,20687,81,0.90 [0.71-1.15],0.4154192232642719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,24443,85,1.31 [0.86-1.99],0.2062534507239632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,21197,76,0.75 [0.30-1.90],0.5409889781225496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24383,84,1.12 [0.85-1.49],0.4117570348603019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",21175,80,1.41 [0.87-2.28],0.161483162446895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,24512,89,1.10 [0.77-1.56],0.5990739572149388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,20705,76,1.18 [0.59-2.35],0.6327475490310785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20704,78,1.10 [0.87-1.39],0.4193969595741992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,23956,85,1.07 [0.83-1.37],0.5992814967929856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,20626,75,0.80 [0.47-1.37],0.4187220254669496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,24518,89,0.86 [0.54-1.38],0.5374426928108469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,20626,75,0.99 [0.49-2.01],0.9789818504651256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,24747,89,0.82 [0.33-2.02],0.659534022232223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,21290,77,0.97 [0.46-2.06],0.9417343071654064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,20813,78,0.42 [0.16-1.08],0.0712351029132816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,21197,76,1.09 [0.80-1.47],0.5895440603817241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,24552,86,0.94 [0.80-1.10],0.4322833841285001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,24518,89,0.67 [0.32-1.40],0.2875553015773635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,24840,86,0.56 [0.26-1.20],0.1372258679892897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,24534,88,1.12 [0.96-1.30],0.1617996522442257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,24593,88,1.62 [0.62-4.22],0.3273917725067656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,23961,82,1.16 [0.62-2.16],0.644105000971423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24530,85,1.05 [0.83-1.32],0.6785561315940428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,24728,86,1.20 [0.86-1.68],0.2804818061019127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,24111,86,1.24 [0.89-1.73],0.2018211102200641
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,20705,76,1.15 [0.87-1.53],0.3215582768532642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,20813,78,1.07 [0.54-2.14],0.8455785724744785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,24837,89,0.75 [0.47-1.19],0.2215067917596654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,24534,88,0.89 [0.58-1.35],0.5743987974326947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,24603,89,1.08 [0.87-1.33],0.4999082860205244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,24530,85,1.01 [0.86-1.18],0.9192992029740712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,24592,89,0.93 [0.55-1.56],0.7791595061893677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,20705,76,1.01 [0.74-1.39],0.9355507454500314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24530,85,0.91 [0.82-1.02],0.1220659961027007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,24490,87,1.14 [0.86-1.50],0.3565854405672445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,24096,86,0.82 [0.56-1.21],0.3229332913656771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21174,77,1.01 [0.83-1.24],0.8920038144912928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,21233,77,1.01 [0.80-1.27],0.933628504962276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,24383,84,1.04 [0.85-1.27],0.7085852085549618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,20687,81,0.99 [0.60-1.66],0.9791662168408366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,20537,77,1.08 [0.81-1.45],0.5848028182382604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,24530,85,0.99 [0.80-1.23],0.9624993105723372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,24420,84,0.97 [0.76-1.24],0.7892599160167634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,23670,82,1.12 [0.90-1.40],0.3090045807816657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,24495,89,0.90 [0.65-1.25],0.522034363547571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,24583,85,1.01 [0.70-1.46],0.9702460185699652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,23961,82,2.06 [1.12-3.78],0.0195538602523265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,21290,77,1.07 [0.71-1.60],0.7450238111158595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,24534,88,1.26 [0.86-1.86],0.236700274618511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,24072,86,1.27 [0.84-1.90],0.258586679115918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,24738,86,0.96 [0.74-1.24],0.7372373781661967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,24501,88,1.03 [0.76-1.40],0.8438783666829939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20626,75,1.12 [0.73-1.71],0.6138977204017114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,20705,76,0.86 [0.56-1.31],0.4750725367172622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,20890,76,0.93 [0.57-1.53],0.7755737890124169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,24517,86,0.89 [0.72-1.09],0.2486844093497845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,20813,78,1.17 [0.86-1.60],0.318228690432163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,24760,86,1.06 [0.58-1.92],0.8518647342184852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,21233,77,1.16 [0.57-2.35],0.6840491864357693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,20890,76,1.48 [1.05-2.09],0.0248443497446875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,20537,77,1.22 [0.72-2.05],0.4588082351730521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,20537,77,0.85 [0.62-1.18],0.3310836898795323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,24111,86,1.19 [0.94-1.51],0.1563365001196948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,24420,84,1.15 [0.93-1.43],0.2030420223762535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24603,89,1.08 [0.84-1.38],0.5561359124925906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,24534,88,0.95 [0.63-1.42],0.8033118602958178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,21138,76,0.54 [0.33-0.88],0.0145282493651024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,21298,80,1.14 [0.53-2.44],0.7440433179504684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,20705,76,1.13 [0.81-1.57],0.4661598613048665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",20626,75,1.34 [0.90-1.99],0.156058854158978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",21257,77,0.67 [0.29-1.52],0.3348181053856442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",23961,82,0.91 [0.44-1.91],0.809102019759766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",20501,77,1.63 [0.79-3.38],0.1851501095960381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21257,77,0.83 [0.58-1.18],0.2973721055927215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",20687,81,1.17 [0.60-2.25],0.6477759288879841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,24389,84,0.98 [0.69-1.38],0.8879554987295605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,20705,76,1.03 [0.57-1.89],0.9116190206517916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,24465,87,1.10 [0.83-1.46],0.4871193425327849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,24776,86,0.95 [0.62-1.44],0.8037903464199587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,24592,89,1.06 [0.82-1.37],0.6425841032605415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,20992,80,0.96 [0.71-1.30],0.7983918253243526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,24111,86,0.91 [0.63-1.31],0.6065478142884095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,20687,81,1.23 [0.98-1.54],0.0772815792297358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21233,77,1.48 [0.76-2.91],0.2518658058718259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20890,76,1.08 [0.89-1.30],0.4436938084338868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",21197,76,1.09 [0.85-1.40],0.48341746425065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,24111,86,1.13 [0.65-1.96],0.6562908881422609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,20626,75,0.97 [0.68-1.37],0.8588304384599963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,21197,76,0.94 [0.77-1.14],0.535664889447284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,21174,77,1.04 [0.84-1.29],0.7261365146920481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,20890,76,0.84 [0.56-1.27],0.4122372657784648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,23961,82,1.19 [0.81-1.74],0.3863453013454129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,24420,84,0.95 [0.87-1.05],0.3447157099636367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,21283,78,0.84 [0.66-1.07],0.1524072366028691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,20537,77,0.76 [0.41-1.42],0.3945436232971203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,24096,86,0.93 [0.73-1.19],0.5720191329678782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,20813,78,0.97 [0.48-1.98],0.9347858150898724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",21290,77,0.92 [0.67-1.26],0.5961265558525168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",20704,78,1.09 [0.86-1.38],0.4725262743125223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21257,77,0.92 [0.65-1.29],0.6224731809169448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,21290,77,1.08 [0.87-1.33],0.4830252408467106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,20626,75,1.46 [1.05-2.03],0.025663384184341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,20537,77,1.00 [0.61-1.64],0.9988372061232604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,21283,78,0.90 [0.74-1.09],0.2937503060130287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20626,75,0.88 [0.49-1.59],0.6756723498155668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,20704,78,0.91 [0.67-1.23],0.5315990497032226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,20704,78,1.07 [0.71-1.61],0.7447906000802211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,20705,76,0.82 [0.62-1.10],0.1818378065145366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20705,76,0.83 [0.50-1.38],0.4768525827190518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,21257,77,1.12 [0.67-1.87],0.6533528268285129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,24096,86,0.99 [0.75-1.33],0.9716508916707528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,24534,88,0.88 [0.58-1.33],0.5429606710622294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,20634,75,1.02 [0.65-1.62],0.9271858196015356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,20626,75,0.90 [0.58-1.41],0.651296725051933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,20813,78,0.84 [0.66-1.06],0.1457552982340717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,24598,90,1.18 [0.82-1.69],0.3694813847537957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,23956,85,0.89 [0.61-1.31],0.5597966127827003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,20626,75,1.26 [0.81-1.95],0.3059668674137379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,20705,76,1.04 [0.87-1.25],0.6452301052724978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,24273,84,1.08 [0.79-1.49],0.6202428936990333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,21174,77,1.22 [0.85-1.74],0.2802107135512997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,24552,86,0.94 [0.67-1.33],0.7371302991290272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,20653,81,1.10 [0.80-1.52],0.5621996476438009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20665,77,0.97 [0.66-1.41],0.8724362007817643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20813,78,0.61 [0.23-1.60],0.3157308136848835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,23956,85,0.80 [0.53-1.21],0.2903595123842166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,21161,76,1.26 [0.73-2.17],0.4091895713571309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,21233,77,1.26 [0.68-2.33],0.460220053725801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",21257,77,1.02 [0.65-1.61],0.9334956215730308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24592,89,0.92 [0.45-1.90],0.8270612853888972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,24096,86,0.92 [0.63-1.35],0.6623947473396115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,24602,90,0.77 [0.42-1.40],0.3887026228230716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,24534,88,0.68 [0.33-1.37],0.275913449784857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,24776,86,1.05 [0.63-1.76],0.8398298392316735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,24489,85,0.88 [0.69-1.11],0.2733921216361523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,24639,90,1.13 [0.95-1.35],0.1567465630483321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,24096,86,0.93 [0.63-1.37],0.7151924093922588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,24497,85,1.19 [0.70-2.04],0.5178799332178573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21197,76,0.94 [0.48-1.83],0.8568212173216743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,24760,86,0.80 [0.40-1.59],0.5298829265436953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,23961,82,1.18 [0.95-1.48],0.134886959209143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21174,77,0.90 [0.61-1.33],0.6130946506602868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20642,81,1.67 [0.98-2.86],0.0608871876298904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21197,76,0.94 [0.74-1.20],0.6264756367901838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23956,85,1.05 [0.84-1.32],0.661356386314088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,20626,75,1.25 [0.76-2.07],0.3829426562067197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,20626,75,1.07 [0.77-1.49],0.6869405998276845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,20687,81,1.00 [0.51-1.93],0.9884681185005972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24524,86,1.29 [0.66-2.50],0.451670429602807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,24592,89,0.75 [0.39-1.44],0.3815492988251281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20687,81,1.40 [0.88-2.24],0.1552869179849582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,20687,81,1.00 [0.55-1.83],0.9877646170602894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,23884,82,1.14 [0.72-1.78],0.5793975537681947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,20890,76,1.15 [0.89-1.48],0.2785580640677962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,24592,89,1.06 [0.68-1.67],0.7944023432590122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,24639,90,1.16 [0.60-2.23],0.6542790717187128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,21174,77,0.99 [0.82-1.21],0.9544112136201052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,21257,77,1.09 [0.42-2.85],0.8599749902603226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,21298,80,1.05 [0.77-1.43],0.7528813620760002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,24840,86,1.48 [0.75-2.93],0.2557740037712627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,20687,81,0.84 [0.64-1.11],0.2184053581940888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24530,85,1.05 [0.87-1.27],0.6212419137065042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",24096,86,0.77 [0.55-1.09],0.1415612718959679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,20704,78,1.05 [0.79-1.40],0.7441375560907988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,21257,77,0.94 [0.55-1.62],0.8242740370588371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20626,75,1.06 [0.79-1.43],0.6757312254211707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,20890,76,0.88 [0.56-1.37],0.5687797536132156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,23956,85,0.94 [0.63-1.40],0.7570894247625504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21197,76,1.07 [0.87-1.32],0.5237563819513371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,20626,75,1.16 [0.85-1.60],0.3487720319316604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,20626,75,1.05 [0.62-1.79],0.8573738649214102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,24383,84,1.67 [0.45-6.18],0.4413373832348471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,21290,77,1.72 [1.11-2.67],0.0159969729490164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,21233,77,1.44 [0.59-3.53],0.4225846511043246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,20329,77,0.80 [0.40-1.60],0.5246021188783305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,24531,90,1.18 [0.73-1.91],0.5058051509550543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,24534,88,1.17 [0.92-1.50],0.2031106448393894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,23956,85,0.71 [0.45-1.12],0.1434240419536351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,20704,78,1.11 [0.69-1.79],0.6603411378730466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,21213,77,1.04 [0.78-1.39],0.7949699415920115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,20705,76,1.01 [0.74-1.38],0.96473478139909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,20634,75,1.41 [1.00-1.99],0.0506980102206875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,20687,81,2.78 [1.31-5.90],0.0078567482818847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,24562,89,0.57 [0.24-1.34],0.1993243921581896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,21087,77,1.21 [0.92-1.60],0.1794673008174697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24383,84,1.04 [0.81-1.33],0.7603983675379392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,20537,77,0.86 [0.48-1.55],0.6169286098115276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21257,77,1.15 [0.86-1.54],0.3554851097570141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,24534,88,0.71 [0.32-1.56],0.3883313373277407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,20626,75,0.94 [0.75-1.17],0.5778055739730312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",23961,82,1.00 [0.70-1.43],0.9875671906526056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",20626,75,1.28 [0.78-2.11],0.3316461215869575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23961,82,1.11 [0.77-1.61],0.5697351013708056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24837,89,0.80 [0.24-2.65],0.7205815531180979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,21283,78,0.75 [0.29-1.90],0.5432635265219716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,24837,89,0.76 [0.43-1.32],0.3284609313306009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,20930,76,1.15 [0.58-2.29],0.6896518428586713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,24552,86,1.03 [0.54-1.94],0.9375669823336048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,20687,81,0.75 [0.39-1.45],0.399014845715119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,20687,81,1.19 [1.01-1.41],0.0380900027028797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,21290,77,1.13 [0.70-1.84],0.6200938193565321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,24111,86,1.15 [0.98-1.34],0.0937366835211009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,24530,85,1.00 [0.66-1.50],0.9822204286037208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,20626,75,1.23 [0.77-1.97],0.3894941309494799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,23956,85,1.10 [0.89-1.35],0.371161926182845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,24534,88,1.35 [0.88-2.09],0.1690194116618017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,21283,78,0.94 [0.49-1.78],0.8405111102311672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,24552,86,1.15 [0.67-1.97],0.6206956478442076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,24760,86,0.99 [0.74-1.33],0.9680412734382724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,24552,86,1.11 [0.56-2.21],0.7633153342353438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,21298,80,1.16 [0.92-1.46],0.2064736112488196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,21257,77,0.60 [0.27-1.32],0.2024704403667601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,24655,90,1.50 [0.77-2.92],0.2284621271670587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,24534,88,0.94 [0.48-1.83],0.8587199078883927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,24096,86,1.42 [1.07-1.88],0.0153369756214026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,20705,76,0.52 [0.23-1.18],0.118874083861327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,24776,86,1.23 [0.93-1.64],0.1485057289398968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21290,77,1.22 [0.92-1.63],0.1686326271659379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21233,77,1.23 [0.66-2.32],0.5153004523011508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,24487,85,1.04 [0.84-1.29],0.7259645653304125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,24592,89,0.79 [0.56-1.13],0.1988289181738387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,24530,85,0.84 [0.48-1.46],0.530762365017885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,23956,85,0.65 [0.34-1.25],0.1984883565269819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,24552,86,1.38 [0.65-2.92],0.4000279064083184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,24776,86,0.46 [0.19-1.11],0.0852182518798435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24552,86,1.24 [1.03-1.49],0.0246343872732485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,24530,85,1.12 [0.90-1.39],0.3239983277396843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21174,77,0.99 [0.80-1.24],0.9557932098534256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,24725,86,1.22 [0.74-1.99],0.4376421239416679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,24840,86,1.08 [0.81-1.46],0.5949796900972453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20704,78,1.67 [1.05-2.65],0.0288206232113078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20626,75,1.01 [0.65-1.56],0.966609499519506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,21165,76,1.03 [0.81-1.32],0.7902021615156409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24420,84,1.02 [0.74-1.42],0.8838564686841961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,24534,88,1.23 [0.86-1.77],0.2500847976017338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,20687,81,1.21 [0.94-1.56],0.1455281580618621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,20626,75,1.74 [1.08-2.79],0.0217839906522127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,20626,75,1.30 [0.76-2.21],0.3379785568206658
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,23961,82,1.25 [0.77-2.04],0.3593604748447929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,20687,81,0.82 [0.41-1.65],0.5841136852673466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,24301,83,0.81 [0.59-1.11],0.189931487565343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21257,77,1.04 [0.63-1.72],0.8909983267346097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,23923,81,1.04 [0.72-1.50],0.827561132733201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,20890,76,0.95 [0.67-1.35],0.7876622548100582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,21197,76,1.04 [0.77-1.41],0.7801378753895879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24420,84,1.25 [0.70-2.23],0.4603952969640141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,24534,88,1.25 [0.78-2.00],0.3474271166477606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20890,76,0.67 [0.43-1.05],0.0844194720066525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,20051,78,1.00 [0.84-1.19],0.984574578496164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,24304,86,1.01 [0.74-1.38],0.9302308088555828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,24639,90,0.80 [0.52-1.21],0.2828139715992515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,24420,84,0.94 [0.70-1.26],0.676764482676822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,20634,75,1.15 [0.77-1.74],0.4969359838669847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,21233,77,1.03 [0.84-1.25],0.8046837207380895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,20704,78,1.00 [0.73-1.36],0.9986662386313212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,24420,84,0.82 [0.52-1.31],0.4044470850752863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,21245,81,1.61 [0.58-4.50],0.3609604232392989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,21233,77,0.85 [0.46-1.59],0.6165773440959568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24562,89,1.22 [0.69-2.13],0.4921801679272256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,24399,85,1.10 [0.85-1.44],0.4654248224458154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,24655,90,1.08 [0.43-2.72],0.863977624061628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,20705,76,0.78 [0.42-1.45],0.4326780618270164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,20634,75,1.44 [1.09-1.88],0.0090724940275279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,21197,76,1.08 [0.75-1.56],0.6858770506428731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,21257,77,1.08 [0.77-1.50],0.6648946129373674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20704,78,1.15 [0.85-1.56],0.3675540156535679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,24776,86,0.94 [0.82-1.07],0.3260931758380584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,24400,89,0.89 [0.56-1.43],0.6398805092242834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,20626,75,1.00 [0.70-1.43],0.9887036310501324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,24096,86,0.77 [0.51-1.16],0.2071735919538998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,23923,81,0.94 [0.72-1.24],0.6780316134309656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,24383,84,1.02 [0.88-1.19],0.797640800534767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21257,77,0.87 [0.70-1.09],0.2393688894338963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20890,76,1.40 [0.95-2.08],0.0887686258544093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,24111,86,1.06 [0.76-1.48],0.7266943015145815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,20704,78,1.28 [0.84-1.95],0.2491549377557488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20494,77,0.83 [0.54-1.30],0.4213797791938447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,23961,82,1.10 [0.81-1.49],0.5308875374862082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,20687,81,1.65 [1.17-2.32],0.0045474222476505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,21082,76,0.83 [0.40-1.70],0.6063281305830927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,21233,77,0.89 [0.49-1.60],0.6960648049682774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,20626,75,0.81 [0.55-1.18],0.2697578925571593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24708,87,0.90 [0.46-1.74],0.7519058090246604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,24534,88,1.03 [0.52-2.04],0.9415338635333316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,24096,86,0.76 [0.50-1.14],0.1851825570018949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,20890,76,1.00 [0.75-1.35],0.9768559890476792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,24534,88,1.34 [0.95-1.91],0.0989086615347457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,24530,85,1.12 [0.84-1.51],0.4411631330530521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,20813,78,1.29 [0.83-1.99],0.2583342835347017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,20537,77,0.74 [0.37-1.51],0.4146223358953322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,23961,82,1.09 [0.74-1.59],0.6658282049453588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21197,76,1.67 [1.03-2.70],0.0380075531356941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,20634,75,1.01 [0.79-1.30],0.9213858553048015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20763,78,0.71 [0.43-1.17],0.178714735463787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,21257,77,1.18 [0.88-1.59],0.2584246604574001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,24757,86,0.55 [0.21-1.48],0.2359442953489415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,21257,77,0.72 [0.30-1.70],0.4525302197481605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,24552,86,0.89 [0.52-1.55],0.6916395932735411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,21197,76,0.90 [0.47-1.74],0.7568111250911698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,21197,76,0.76 [0.42-1.38],0.3653305062195444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,21174,77,1.03 [0.60-1.77],0.923083271347193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,20537,77,1.22 [0.97-1.53],0.0950213339707588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,21174,77,0.75 [0.44-1.27],0.2791584953638325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,24837,89,0.87 [0.54-1.40],0.5702649421150603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,21197,76,0.98 [0.74-1.30],0.8705593673558082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,21290,77,1.11 [0.89-1.38],0.351147365728752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24725,86,0.95 [0.58-1.55],0.8447035474243958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,24420,84,1.19 [0.64-2.21],0.5866841452261427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,24776,86,1.36 [0.99-1.85],0.0547153004758759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,24552,86,1.24 [0.90-1.71],0.1860318166816015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,20537,77,0.79 [0.48-1.30],0.3567579289709864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20537,77,1.10 [0.76-1.60],0.6051122011396382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20626,75,1.27 [0.99-1.64],0.0624503454743113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20813,78,1.06 [0.86-1.31],0.5782780872304016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,24837,89,1.15 [0.89-1.49],0.2734556312991716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,24639,90,1.07 [0.86-1.33],0.546134619433514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,23956,85,1.10 [0.57-2.13],0.7716836557415678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,24552,86,1.66 [0.86-3.20],0.1302878353980302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,24837,89,0.88 [0.52-1.49],0.6282557307527182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,20537,77,0.92 [0.52-1.64],0.7815309267388683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,20813,78,1.24 [0.59-2.62],0.5681367548699698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,21283,78,1.14 [0.81-1.60],0.4523743707106646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,20537,77,1.31 [0.99-1.72],0.0554096544432126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,21257,77,1.04 [0.86-1.24],0.700239482739749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,24639,90,1.04 [0.90-1.20],0.6194890466523785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23956,85,0.87 [0.58-1.32],0.5246725948639024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,20705,76,0.88 [0.56-1.39],0.5898124667389171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20537,77,0.99 [0.66-1.48],0.9648417654481334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,20626,75,1.08 [0.75-1.55],0.6870747022804864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20687,81,0.90 [0.55-1.47],0.6663750207430887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,24837,89,1.44 [0.63-3.29],0.3836428165936382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,24534,88,1.23 [0.90-1.68],0.1874927976290107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,24534,88,0.94 [0.50-1.76],0.8509175957633341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,20704,78,0.83 [0.38-1.82],0.6478378175402169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,20813,78,0.50 [0.22-1.10],0.0855655216449485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,21298,80,0.81 [0.36-1.82],0.6036935978151583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,20687,81,1.21 [1.02-1.43],0.0310458058470678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,21158,81,1.08 [0.87-1.33],0.4890508951986405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,23961,82,1.11 [0.78-1.57],0.560331174237473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,20537,77,0.99 [0.66-1.49],0.9619615783069088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,20705,76,1.21 [0.93-1.58],0.1606116543364138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24386,84,1.17 [0.91-1.49],0.2173098876042451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,21298,80,0.92 [0.66-1.28],0.6179906998342877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21290,77,1.08 [0.73-1.60],0.6959074501659643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,24840,86,0.63 [0.27-1.46],0.2835733075541966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,24700,89,0.79 [0.49-1.25],0.3114304367324185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21043,81,1.27 [0.63-2.59],0.5029625120243104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,20626,75,1.03 [0.72-1.47],0.8741974222135852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,20705,76,0.90 [0.60-1.37],0.6317168922508353
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,20687,81,0.93 [0.74-1.17],0.5606555822949122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,21257,77,1.02 [0.85-1.23],0.822793146629319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,21197,76,1.14 [0.76-1.70],0.5355547105159899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,20537,77,0.97 [0.75-1.24],0.8011018186898086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24383,84,1.23 [0.63-2.41],0.5364129371599449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20813,78,0.93 [0.55-1.56],0.7791777260297388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,21298,80,1.26 [0.52-3.06],0.6141634791818043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,24196,88,1.14 [0.81-1.59],0.4480999188443968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21257,77,1.01 [0.76-1.33],0.95789599248282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,24229,84,0.97 [0.58-1.61],0.8930283101980188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24530,85,1.06 [0.78-1.44],0.7176760731234035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24534,88,1.32 [0.63-2.75],0.4566420930100048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20687,81,1.06 [0.74-1.50],0.7672836529835145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24534,88,0.84 [0.54-1.32],0.4511091006008346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,24552,86,0.93 [0.67-1.29],0.6522320504763042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20813,78,0.74 [0.55-0.99],0.0451556781176751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,20494,77,1.03 [0.78-1.35],0.8425591416567813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,21290,77,1.10 [0.47-2.53],0.8301301490567725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,20626,75,0.86 [0.58-1.28],0.4643390086179972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,24551,88,0.96 [0.72-1.28],0.7555091521842225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,20890,76,1.06 [0.80-1.40],0.7051703709129493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,24383,84,1.11 [0.80-1.54],0.5294010151140848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,24592,89,0.92 [0.47-1.82],0.8175587683936196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,24794,89,0.89 [0.57-1.39],0.6080035445039838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",24479,88,1.23 [0.92-1.63],0.1599690408466865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,24639,90,1.16 [0.94-1.43],0.1560252524450856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,24534,88,0.79 [0.43-1.47],0.4608240609992622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,24747,89,0.85 [0.59-1.22],0.3762303918823322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,24534,88,0.92 [0.47-1.80],0.8050021410372071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,24354,89,1.07 [0.55-2.09],0.8357177937881832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",21233,77,0.75 [0.53-1.07],0.1111155364445978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20687,81,1.24 [0.85-1.83],0.2624657341853442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21233,77,0.99 [0.80-1.23],0.9305338300489676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21233,77,1.23 [0.91-1.67],0.1701345083291668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,20762,79,0.82 [0.31-2.13],0.6777902964983193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,23961,82,1.05 [0.60-1.84],0.8618236587083479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,24552,86,1.51 [1.01-2.25],0.0429245669209628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,24552,86,1.30 [0.99-1.71],0.0546838743255211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,21202,77,0.87 [0.60-1.26],0.4684053418499891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,24742,88,0.74 [0.45-1.21],0.2276301766409371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,23956,85,0.54 [0.27-1.09],0.0857187737799682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,21233,77,1.66 [0.84-3.29],0.1462453762403268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,24530,85,1.04 [0.82-1.32],0.7498465598104906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,24720,89,1.99 [0.93-4.26],0.0780781684460369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,24472,86,1.20 [0.81-1.77],0.3599888706765648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24458,86,0.93 [0.85-1.03],0.1632320037088045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,20626,75,0.98 [0.74-1.30],0.8834016893465843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,20626,75,1.39 [0.98-1.97],0.0667585155051292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,20705,76,1.40 [0.99-1.98],0.0573161748434205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,23923,82,1.03 [0.86-1.24],0.7161659021087382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,21298,80,0.79 [0.56-1.12],0.1898333626696232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,21233,77,1.28 [0.98-1.68],0.0698141418179735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,24518,89,1.02 [0.95-1.09],0.57222945204325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,20704,78,1.20 [0.86-1.69],0.2799394071567858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,20634,75,1.04 [0.63-1.73],0.8775611950000475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",24096,86,0.94 [0.79-1.11],0.436842685470267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,24420,84,1.40 [0.39-5.00],0.6055580193090386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,24592,89,0.69 [0.35-1.34],0.2706227209695027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,20687,81,1.47 [1.02-2.10],0.0376333397782183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,20687,81,1.41 [0.74-2.67],0.2950544806331727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24420,84,1.12 [0.67-1.85],0.6687065886775613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,20704,78,0.61 [0.45-0.84],0.0023580042131325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,21298,80,0.53 [0.25-1.14],0.1065963486944468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,24111,86,0.80 [0.46-1.39],0.4347106788197032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,24639,90,1.41 [0.67-2.96],0.366148318113883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,21283,78,0.63 [0.35-1.13],0.1229721947767013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,21150,81,1.16 [0.91-1.48],0.2281895501168103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,24776,86,1.48 [1.01-2.18],0.0452151037699094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,24524,88,1.13 [0.93-1.38],0.2201193670074264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,20890,76,1.10 [0.79-1.52],0.5712478632685922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21283,78,1.18 [0.87-1.62],0.2859015330518286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,20687,81,1.46 [0.84-2.53],0.1798236787326043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,23956,85,1.55 [0.96-2.51],0.0731328603029897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,20687,81,0.96 [0.68-1.36],0.8176012531449088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,21290,77,1.24 [0.83-1.84],0.2922777387238006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,24420,84,1.19 [0.87-1.64],0.2840352750535636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21174,77,1.10 [0.85-1.42],0.469117884635977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24592,89,1.05 [0.87-1.28],0.6007946016866674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20890,76,0.97 [0.71-1.33],0.8603253471181536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21257,77,1.01 [0.76-1.33],0.9548696578550476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21257,77,0.83 [0.45-1.53],0.5484871616677409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,24552,86,1.16 [0.92-1.45],0.2153076933409607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,24840,86,1.10 [0.90-1.34],0.3506965616127061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21197,76,1.01 [0.84-1.21],0.9219950722475708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,24383,84,1.01 [0.64-1.60],0.9583316183204992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,20705,76,1.05 [0.81-1.37],0.7145079360859531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,24465,88,0.88 [0.72-1.06],0.1690616959990813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,23956,85,0.79 [0.53-1.18],0.2503381621023174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,20537,77,1.00 [0.42-2.39],0.993434899370231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,21283,78,1.43 [0.82-2.47],0.2046565400070817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,21174,77,0.67 [0.33-1.34],0.2532712646163001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,24673,89,1.01 [0.55-1.86],0.967724507086615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,23878,82,1.04 [0.84-1.30],0.6919606797395537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,20956,80,1.12 [0.80-1.56],0.5032389972354723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",24096,86,1.03 [0.79-1.34],0.8487271991706749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",24840,86,1.08 [0.82-1.43],0.5926173459965597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,24760,86,0.88 [0.64-1.22],0.4510285900087188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,24096,86,0.96 [0.49-1.86],0.8925912198939219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,24518,89,0.70 [0.34-1.43],0.3273298723263368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,21283,78,0.86 [0.56-1.32],0.4877936369516316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,21283,78,0.65 [0.42-1.00],0.0496735998401408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,24096,86,1.10 [0.79-1.54],0.5669712750564943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20705,76,1.00 [0.49-2.03],0.9938778700227838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24552,86,1.11 [0.89-1.39],0.3592437714048866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21192,76,0.94 [0.72-1.23],0.6691610507538295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,24096,86,1.29 [0.88-1.90],0.1965763184794935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,20626,75,1.04 [0.65-1.66],0.8707740360797369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,20813,78,1.06 [0.90-1.26],0.4819812936086506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23956,85,1.10 [0.83-1.46],0.5049795609839904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,24776,86,0.99 [0.76-1.27],0.9110489852120462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,21233,77,1.29 [0.85-1.95],0.2295011686053763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,24573,90,1.51 [0.73-3.12],0.2705516136113702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,20626,75,0.95 [0.50-1.80],0.8719710949624413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,24530,85,0.96 [0.69-1.35],0.8268215583577844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,21319,81,1.02 [0.43-2.40],0.970045974540268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,20675,78,1.11 [0.82-1.50],0.5053181924076866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,20687,81,1.05 [0.67-1.66],0.8214172977035828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,20704,78,0.79 [0.43-1.45],0.4482828359627598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,24602,90,1.02 [0.72-1.45],0.9170158687965372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,20687,81,1.19 [0.67-2.12],0.5592753867682438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,24462,86,1.17 [0.73-1.88],0.5052101771688338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,21233,77,0.64 [0.36-1.16],0.1411536929079169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,24428,89,1.01 [0.64-1.60],0.9535929619221304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23961,82,1.10 [0.92-1.32],0.2953909766097784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,24760,86,1.15 [0.53-2.49],0.7191175002702082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,23914,87,1.07 [0.73-1.57],0.7351451742729709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,20890,76,0.50 [0.21-1.20],0.1213927667395085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,21090,76,1.54 [0.77-3.08],0.2170316662078524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,21197,76,0.97 [0.63-1.51],0.9001598274740235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,21197,76,0.96 [0.89-1.04],0.3396240416472566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,24383,84,0.95 [0.81-1.12],0.5403595767318439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,24530,85,1.09 [0.83-1.43],0.5403193197820708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,23956,85,0.84 [0.54-1.30],0.4268226702012826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,20537,77,0.82 [0.39-1.73],0.6090376103354443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,21257,77,0.81 [0.52-1.28],0.370485715707787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,20705,76,0.96 [0.63-1.48],0.8634720371674106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,24420,84,0.90 [0.63-1.28],0.543734180645675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,24356,84,1.40 [0.84-2.33],0.192178406333458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,24270,83,1.26 [0.74-2.13],0.3969023457817118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,24530,85,1.18 [0.82-1.71],0.3781989341281746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,20687,81,1.17 [0.82-1.66],0.3969340695391514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,24530,85,1.13 [0.92-1.39],0.2560201060050345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,23956,85,0.81 [0.57-1.15],0.235436398356599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,20042,77,1.10 [0.90-1.36],0.3551013490346383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23961,82,1.42 [0.75-2.68],0.2791234541744681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24332,88,1.08 [0.56-2.07],0.8186208284529018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,20532,81,1.53 [1.06-2.19],0.0223289658420031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,21290,77,0.83 [0.63-1.10],0.1912625459819769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,20705,76,0.86 [0.65-1.15],0.309940138932341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24530,85,1.20 [0.79-1.83],0.3970841118100906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,23961,82,1.04 [0.62-1.75],0.8901771683204489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,24111,86,1.68 [1.20-2.35],0.0027368433552302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,20687,81,1.04 [0.69-1.56],0.8532079035272343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24383,84,1.12 [0.89-1.43],0.3360839349033802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24603,89,1.12 [0.90-1.39],0.2983500886717246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20643,80,1.31 [0.86-2.01],0.2089188416850208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,21290,77,0.53 [0.26-1.11],0.0911096697311684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,21283,78,0.88 [0.33-2.33],0.7977314574629308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,24837,89,0.77 [0.40-1.48],0.430095101376339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,21197,76,0.99 [0.63-1.54],0.9477127413304974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21197,76,1.84 [0.93-3.67],0.0816763497308675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24484,85,0.64 [0.29-1.43],0.2774211164143056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24291,82,1.16 [0.62-2.17],0.6331069938047049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,21233,77,1.04 [0.58-1.88],0.8918747991261582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,24837,89,1.35 [0.64-2.87],0.4304513921898998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21290,77,0.69 [0.34-1.39],0.2982839936867073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20813,78,1.33 [0.93-1.89],0.1197489211085067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23853,82,0.90 [0.62-1.31],0.5818303158442666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,20890,76,1.00 [0.60-1.67],0.9938413359174786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,24530,85,1.06 [0.72-1.56],0.7711888036015493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,24666,86,1.06 [0.90-1.25],0.5037503841177808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,24776,86,1.45 [0.90-2.34],0.1241548960063064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,21174,77,0.83 [0.53-1.29],0.4029898859390273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,23961,82,0.75 [0.50-1.12],0.1590155063271709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,20704,78,1.53 [1.05-2.24],0.0274591512497973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,20626,75,1.23 [0.99-1.54],0.0587926729275342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,21319,81,0.96 [0.62-1.50],0.8729185577561712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,24433,85,1.29 [0.84-1.99],0.2465786153952367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,24538,89,0.50 [0.27-0.94],0.0326799670674318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,20875,78,1.26 [0.90-1.77],0.1824117342459734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,21290,77,1.00 [0.67-1.50],0.9851672990797798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,21290,77,0.99 [0.81-1.20],0.892042345043131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,21290,77,1.01 [0.77-1.31],0.9613406872326564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,21174,77,1.03 [0.73-1.45],0.8706113572550344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,20626,75,1.13 [0.82-1.57],0.4439045583127136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,24096,86,0.91 [0.71-1.16],0.4348757105673378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,20626,75,0.95 [0.73-1.24],0.6994252928820797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20634,75,0.81 [0.52-1.27],0.3604594043629597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,21174,77,0.79 [0.45-1.37],0.3985832996122981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,24530,85,0.88 [0.58-1.34],0.5488069994275877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,23961,82,1.15 [0.79-1.68],0.4699803919941753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,20813,78,1.11 [0.84-1.46],0.4539203386442964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,23956,85,0.76 [0.53-1.10],0.1458934528865804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,24096,86,0.97 [0.70-1.34],0.8556024480057776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,20705,76,0.60 [0.37-0.98],0.0432429090483584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,23956,85,1.17 [0.78-1.75],0.4462344126854691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,20890,76,1.33 [1.02-1.74],0.0385882029786587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,20687,81,1.20 [0.59-2.41],0.6168099343864131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,21174,77,1.12 [0.77-1.63],0.5637007189092474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,20704,78,1.12 [0.75-1.69],0.5728039958004253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,20634,75,1.30 [0.71-2.38],0.3920918658632855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,23956,85,1.11 [0.78-1.58],0.5764432378038384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,20687,81,0.68 [0.44-1.04],0.07579491994842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,20890,76,0.90 [0.59-1.38],0.6246156276578756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,23956,85,1.57 [1.10-2.23],0.0119732480118587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,24655,90,1.37 [0.97-1.93],0.0750900709695718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,23961,82,1.10 [0.63-1.94],0.7286662471460508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20537,77,1.13 [0.69-1.84],0.6301004853082177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,23956,85,0.82 [0.56-1.19],0.2994575192151775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21257,77,1.02 [0.58-1.79],0.9572902169059256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,23983,82,0.84 [0.57-1.25],0.3966734213927451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,21257,77,1.07 [0.81-1.42],0.6123760902040433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,20626,75,1.41 [1.00-2.00],0.0518799529752894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,20537,77,0.89 [0.54-1.46],0.6494201617205144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,20705,76,0.75 [0.50-1.14],0.1771160740929974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,24420,84,1.06 [0.82-1.36],0.6627606380989448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,24420,84,0.75 [0.52-1.08],0.1258136048061761
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,21197,76,0.83 [0.57-1.20],0.3259401755485748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,20687,81,1.01 [0.74-1.38],0.9570277977606864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,20704,78,0.99 [0.80-1.22],0.9358952565830276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,21174,77,1.18 [0.84-1.68],0.3426891044256152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,24111,86,0.93 [0.59-1.46],0.7502811744882355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20704,78,1.18 [0.41-3.35],0.7594892409363356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,21257,77,0.96 [0.68-1.37],0.8418393439774452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,24382,87,1.22 [0.84-1.77],0.2923302104795913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,24837,89,1.26 [0.93-1.71],0.1410538489682094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,24837,89,1.14 [0.85-1.54],0.3728194353328812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,21174,77,1.17 [0.68-2.01],0.5695211955044622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,24562,89,0.83 [0.56-1.25],0.37650622511189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,20687,81,1.22 [0.84-1.76],0.296459780721256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24534,88,1.34 [0.67-2.69],0.4143359206265159
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REN,Renin,24552,86,1.00 [0.76-1.32],0.9910293496764796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,20687,81,1.84 [1.23-2.75],0.0028426127503742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,20537,77,0.79 [0.40-1.55],0.4907207947485957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24420,84,1.11 [0.67-1.84],0.6892652789720283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,24463,88,0.77 [0.48-1.24],0.2850865830522329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",20626,75,0.99 [0.62-1.58],0.9689129319881292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,21174,77,0.95 [0.35-2.55],0.919788727127488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,21257,77,0.96 [0.73-1.28],0.7857294498135501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20890,76,1.13 [0.82-1.54],0.457584806150081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,24776,86,1.04 [0.57-1.92],0.8932457907238622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,24776,86,0.97 [0.46-2.04],0.9430670631725572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,21257,77,1.03 [0.73-1.47],0.8517441720087762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,24096,86,1.04 [0.79-1.39],0.7639468545084814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,24232,84,1.05 [0.89-1.24],0.525329038603308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,20687,81,1.15 [0.77-1.72],0.4818469430551441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20813,78,0.82 [0.52-1.30],0.3986320491387026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,24697,86,1.11 [0.81-1.52],0.5307766056968941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,21290,77,1.08 [0.87-1.34],0.4911430923905282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20626,75,0.98 [0.70-1.38],0.9247553001263936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,21257,77,0.75 [0.46-1.24],0.2669140738304166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,20781,78,0.86 [0.65-1.13],0.2793787132802923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,21298,80,1.06 [0.42-2.66],0.9025110440551076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,20704,78,1.53 [1.10-2.11],0.0111108051983814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,24427,86,0.99 [0.83-1.17],0.8764984736405532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,20611,79,1.19 [0.53-2.69],0.6759781110929501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21143,79,1.02 [0.47-2.20],0.9581707363794136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,21257,77,0.99 [0.64-1.52],0.9549781386220828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24717,89,1.07 [0.52-2.21],0.8489535826511017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,20704,78,1.32 [0.65-2.65],0.4419391611667286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,20687,81,1.12 [0.69-1.81],0.6424369000120758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,20687,81,0.98 [0.55-1.77],0.9557044806614036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,20890,76,1.14 [0.84-1.54],0.3934830769611424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,23956,85,1.06 [0.81-1.40],0.6567898598877802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,20890,76,1.16 [0.84-1.60],0.3765533343145154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,20704,78,0.90 [0.68-1.21],0.4981305910349998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,24562,89,0.74 [0.33-1.69],0.48079356607287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,24776,86,0.91 [0.39-2.11],0.8299643776594209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,20704,78,1.79 [0.53-6.07],0.3493468628252185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24552,86,0.83 [0.45-1.54],0.5592941878497397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,24420,84,1.05 [0.67-1.64],0.8253818775038962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,20687,81,1.52 [0.86-2.69],0.1495911174415536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,20890,76,0.94 [0.68-1.29],0.6834020689038197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,20705,76,1.09 [0.65-1.83],0.7495277585788436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,20704,78,1.23 [0.77-1.96],0.3775331534858136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,20626,75,1.35 [0.89-2.05],0.1590052076151161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,20705,76,1.02 [0.87-1.21],0.7904712744433462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23956,85,1.13 [0.79-1.63],0.5096590785670891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23956,85,1.15 [0.87-1.51],0.3295654874364133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,20634,75,1.05 [0.82-1.33],0.7087029306752555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,24383,84,0.94 [0.54-1.64],0.8293883851418786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,24760,86,1.49 [0.74-2.99],0.2631615726601103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,24420,84,1.97 [1.04-3.71],0.0367185664788395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,20626,75,1.19 [0.84-1.69],0.3195608054266748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21257,77,1.09 [0.86-1.37],0.4754668934555437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,24760,86,0.76 [0.42-1.35],0.3453505590295209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,23956,85,0.86 [0.69-1.07],0.1740795076235629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,24776,86,1.29 [0.96-1.73],0.0927224280145862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,20626,75,1.24 [0.69-2.21],0.4723465335876647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,24352,86,0.94 [0.63-1.41],0.7664396382105073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,24188,84,0.81 [0.62-1.06],0.1185615521964263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,20687,81,1.88 [1.16-3.05],0.0104300699852721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,21257,77,0.84 [0.54-1.30],0.4287446654922863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,23923,81,1.17 [0.88-1.56],0.2740896683433843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,21174,77,0.90 [0.51-1.58],0.708101980321078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,24592,89,1.08 [0.78-1.50],0.6468494909517725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,21257,77,0.95 [0.59-1.53],0.8402032081069798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,24111,86,0.99 [0.70-1.39],0.9348939488708464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,21319,81,1.46 [1.01-2.10],0.0428244122666809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21257,77,1.17 [0.56-2.43],0.6789733497189383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,20634,75,0.70 [0.45-1.09],0.1116134901066239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24530,85,1.12 [0.87-1.44],0.3982454144977785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,20890,76,1.00 [0.74-1.34],0.9938819749142048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,21223,77,1.04 [0.85-1.26],0.7103639275387109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20626,75,1.25 [0.82-1.92],0.3033989152892941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,20626,75,0.98 [0.62-1.55],0.9408393944507204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,20890,76,1.22 [0.96-1.57],0.1100456924698387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,21257,77,1.00 [0.49-2.03],0.9939860562840124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,21244,77,1.29 [0.69-2.38],0.4261509811308351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,24420,84,1.08 [0.86-1.35],0.5124803812838463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,24776,86,1.21 [0.62-2.35],0.5717371887317694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,23961,82,0.71 [0.45-1.13],0.1507457959615303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23915,83,0.92 [0.45-1.89],0.8164058698361433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,24837,89,1.37 [0.89-2.09],0.1502244301439697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,24776,86,1.18 [0.59-2.38],0.6357345582740004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,24662,86,0.96 [0.52-1.78],0.901131324732582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,24562,89,1.15 [0.65-2.03],0.6339288695454919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,24572,90,0.83 [0.60-1.15],0.2690784817692422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,20626,75,1.31 [0.73-2.35],0.3664938270900574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,20813,78,0.59 [0.25-1.42],0.2405883999923508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,24603,89,1.12 [0.90-1.40],0.2971355698302035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,24096,86,1.31 [0.86-2.00],0.2039217427643481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,20634,75,1.30 [1.02-1.65],0.0342476414037082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,24697,86,0.70 [0.46-1.05],0.0827666270824391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,20634,75,1.16 [0.77-1.75],0.4781073569593588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,20705,76,0.95 [0.43-2.07],0.8931151421650156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,20705,76,0.73 [0.37-1.44],0.362338833440986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,20634,75,1.04 [0.64-1.68],0.8876321452291622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,20704,78,1.27 [0.77-2.09],0.349169436397549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,23956,85,0.72 [0.53-0.99],0.0440058817416158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,20632,77,1.06 [0.69-1.63],0.7802202658780404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,21290,77,1.14 [0.51-2.54],0.7443140037018148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,20704,78,0.92 [0.72-1.19],0.5419863451706359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,24530,85,0.96 [0.68-1.36],0.8349141383310104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,20705,76,0.99 [0.61-1.62],0.9714301608894342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,24552,86,1.37 [0.87-2.16],0.1717236100352191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,24552,86,1.07 [0.71-1.63],0.740569505113645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,21174,77,0.98 [0.81-1.19],0.8700956375567515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,21197,76,0.94 [0.68-1.31],0.7229766005627191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,20813,78,1.20 [0.68-2.14],0.5268761049566169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,20704,78,1.04 [0.78-1.38],0.794310047072072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,20704,78,1.34 [0.87-2.08],0.1827304327483679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,24837,89,0.87 [0.60-1.26],0.474348916077779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,21319,81,1.37 [0.56-3.36],0.4884706119536741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21319,81,1.14 [0.45-2.89],0.7874152679445559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,24602,90,1.25 [0.91-1.72],0.1643394410507048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,24530,85,1.84 [0.94-3.60],0.0752534484738513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,24552,86,1.26 [0.60-2.64],0.5357968169116668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,20813,78,1.01 [0.62-1.66],0.965516200212002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,24420,84,0.74 [0.35-1.57],0.4367345117807995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,24776,86,1.53 [0.81-2.89],0.1866920347625002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,20687,81,1.71 [0.93-3.16],0.0847415458292019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24747,89,1.25 [0.62-2.53],0.5356581473023256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,21257,77,1.14 [0.87-1.48],0.3410357163316949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,20890,76,0.90 [0.57-1.44],0.6677962567803593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,21185,77,1.42 [0.77-2.62],0.2645510883865323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,24420,84,1.04 [0.54-1.98],0.9155963186875652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,20934,81,7.53 [1.60-35.40],0.0105873766585107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,24837,89,1.24 [0.79-1.96],0.3480866181618237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,23878,83,0.98 [0.82-1.18],0.8681505908276158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,21254,81,2.15 [0.65-7.10],0.2105455001639491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,20931,79,1.04 [0.41-2.60],0.9415055203002648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,21006,79,1.30 [0.74-2.26],0.3617886884996665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,21319,81,0.96 [0.27-3.40],0.9553277172216992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,21319,81,0.72 [0.23-2.26],0.5714843964711687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,24298,84,0.85 [0.64-1.13],0.2554535511769518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,24457,87,1.13 [0.92-1.38],0.2429026921251453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,24111,86,1.29 [0.87-1.93],0.2072789834935892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,24697,84,1.36 [1.00-1.86],0.0536712183772853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,24840,86,0.94 [0.68-1.31],0.7254961194337062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,24383,84,1.00 [0.56-1.79],0.9882786061094392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,21277,81,1.14 [0.27-4.87],0.8608252844990724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,21277,81,1.92 [0.91-4.03],0.0856843011217274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,24837,89,1.11 [0.84-1.46],0.4588029500119881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,21290,77,1.02 [0.74-1.42],0.8969862966907189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,21012,81,1.07 [0.48-2.39],0.8724530174442113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,20927,81,1.75 [0.38-8.00],0.4677566663856615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,21277,81,1.14 [0.37-3.53],0.8219659481413663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,20890,76,1.00 [0.84-1.19],0.991641969879584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,20767,78,1.04 [0.51-2.11],0.9221938922049008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,21197,76,0.88 [0.60-1.31],0.5315749993261398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23961,82,0.94 [0.69-1.27],0.6727100157850403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,24306,84,0.62 [0.37-1.04],0.0699534652177311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,20705,76,0.87 [0.42-1.82],0.7170736849057919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,24592,89,0.57 [0.30-1.08],0.0831497028014178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,24420,84,1.10 [0.49-2.49],0.8143488592121628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,24420,84,1.14 [0.89-1.46],0.30654445798502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,24298,83,1.00 [0.63-1.57],0.9843350679969604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,20813,78,0.86 [0.50-1.48],0.5909786729560604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,23956,85,0.97 [0.69-1.37],0.8718931715502258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,23956,85,1.25 [0.88-1.78],0.214362666491733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,24552,86,0.98 [0.74-1.31],0.9174880459671312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,20951,75,0.82 [0.54-1.24],0.342431202158541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,23956,85,1.10 [0.91-1.34],0.3257378506181394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,24530,85,1.01 [0.73-1.40],0.9360071300106094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20634,75,1.05 [0.74-1.49],0.7854977717508064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,21197,76,0.89 [0.56-1.41],0.6085807264535932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,20762,76,0.96 [0.74-1.24],0.7470651358538124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,21233,77,1.12 [0.81-1.54],0.5067872793975063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,21298,80,0.88 [0.57-1.35],0.5506128388627332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,20537,77,1.02 [0.84-1.23],0.8667112917540576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,20591,75,1.05 [0.81-1.35],0.71843435402054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,20687,81,0.95 [0.57-1.60],0.8551133425560069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21283,78,1.56 [0.75-3.25],0.2298956399718802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",24603,89,1.09 [0.88-1.35],0.4228058866921184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,20890,76,0.92 [0.52-1.61],0.7626109584897776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,24549,89,1.15 [0.78-1.70],0.4742599161715677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24639,90,1.34 [0.86-2.07],0.19152117879848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24530,85,1.01 [0.55-1.84],0.9819755685177868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23961,82,0.85 [0.63-1.14],0.2833865449343961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,24534,88,1.18 [0.96-1.44],0.1094858694156439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24760,86,0.90 [0.50-1.63],0.7375959620725934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24552,86,1.65 [0.84-3.23],0.146263832605229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20704,78,1.45 [0.89-2.35],0.132247184689661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24729,86,0.90 [0.47-1.70],0.7390435653562534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,20704,78,0.75 [0.35-1.62],0.4670654791064101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24583,88,0.96 [0.70-1.33],0.828366821660028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,24466,88,1.03 [0.67-1.56],0.9065488329021948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,20687,81,1.04 [0.83-1.30],0.7362590076859858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,24420,84,1.13 [0.91-1.40],0.2757564266762861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23961,82,0.82 [0.55-1.22],0.3290451576662053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,24096,86,1.11 [0.79-1.56],0.5488389145594126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,24335,83,0.92 [0.70-1.20],0.5483695678324976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,24639,90,1.02 [0.86-1.22],0.7975537908718338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,20626,75,1.50 [1.03-2.19],0.0340470035751291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,21257,77,1.03 [0.84-1.26],0.81191844391476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,24096,86,0.88 [0.64-1.22],0.4475758452732513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23956,85,1.02 [0.61-1.71],0.933756679550729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,24530,85,0.89 [0.64-1.24],0.4798336155568671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23956,85,0.91 [0.63-1.31],0.6118282261376777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,20626,75,1.34 [0.69-2.60],0.382678372504561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,21174,77,1.10 [0.80-1.52],0.5577065849655425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,23961,82,0.83 [0.57-1.21],0.3410481250826234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,20705,76,0.90 [0.58-1.40],0.6449912235132496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,23961,82,1.01 [0.76-1.34],0.9646012945263068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,20537,77,1.04 [0.73-1.47],0.837167477559899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,20537,77,1.27 [0.88-1.85],0.2032657864012812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,23961,82,1.70 [1.10-2.63],0.0171347238242445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,24530,85,0.95 [0.66-1.38],0.8014509762664631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,20705,76,0.83 [0.57-1.22],0.3423724521116005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,21283,78,0.92 [0.58-1.44],0.7063031245205691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,20626,75,0.87 [0.63-1.20],0.3822245635354436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20813,78,1.15 [0.90-1.47],0.2735734118781427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21197,76,0.87 [0.54-1.42],0.5839923893707022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20537,77,1.00 [0.68-1.47],0.9983120659373288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,23961,82,0.79 [0.53-1.19],0.2547305636519724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,20687,81,0.71 [0.37-1.38],0.309080922566613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,24760,86,0.82 [0.51-1.33],0.4227738956745561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,24111,86,1.13 [0.65-1.96],0.6706766852542532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,20890,76,0.82 [0.58-1.17],0.2740937599463819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,21197,76,0.89 [0.68-1.17],0.4197130266560336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,21131,76,1.05 [0.59-1.87],0.8727927926751627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,23956,85,1.13 [0.90-1.42],0.2869082243788372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,21174,77,1.23 [0.91-1.65],0.1777844272548194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,21174,77,1.25 [0.84-1.88],0.2742770360998313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,24420,84,1.00 [0.39-2.60],0.9994783581954158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,23961,82,0.93 [0.70-1.22],0.5883788148464333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,20537,77,0.98 [0.65-1.48],0.9280893824299102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,21197,76,1.01 [0.72-1.40],0.9671539772495684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,24760,86,1.37 [0.78-2.43],0.2772337095226849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,24639,90,0.79 [0.48-1.31],0.3627086151339341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,24654,83,1.26 [0.88-1.81],0.2149641289904251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,20687,81,0.70 [0.43-1.17],0.1721787602678121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24587,89,1.00 [0.76-1.34],0.9760819041843212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21174,77,0.61 [0.39-0.96],0.0306976100540896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,20634,75,0.91 [0.63-1.31],0.6097741179870146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,21185,76,0.81 [0.63-1.05],0.1060504786253043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,24552,86,1.14 [0.91-1.43],0.2410807765724678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,20634,75,0.89 [0.55-1.44],0.6422611457446384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,24592,89,1.02 [0.84-1.26],0.8118943255879016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,21257,77,0.89 [0.61-1.30],0.5576043237191953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,20813,78,1.08 [0.89-1.30],0.4355382937829986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,24383,84,1.14 [0.84-1.54],0.3950178198421493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20704,78,0.68 [0.33-1.40],0.2968588477880022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21233,77,1.12 [0.78-1.63],0.5353616727813909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,20626,75,1.10 [0.81-1.49],0.5500012934653407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,20813,78,1.24 [0.84-1.82],0.2806945467012394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,21197,76,1.09 [0.69-1.73],0.7206628512819674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,21174,77,1.09 [0.85-1.41],0.4931347639134368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,20704,78,1.40 [0.73-2.68],0.3162615954850957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,24552,86,1.31 [1.01-1.70],0.0438040268574349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],24005,88,1.36 [0.94-1.97],0.1016203960893535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",24534,88,1.14 [0.70-1.86],0.5989770499883289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,21298,80,1.07 [0.78-1.48],0.6628448342373472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,21257,77,0.57 [0.27-1.17],0.124838993770086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23956,85,1.24 [0.69-2.20],0.472713975058215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,24651,86,0.92 [0.70-1.21],0.5489743727730565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,24524,86,1.37 [0.83-2.24],0.2160169053975726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,24524,86,1.21 [0.74-1.98],0.4422373676007853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20705,76,0.68 [0.38-1.20],0.178313360636505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,21221,77,0.90 [0.35-2.29],0.8180695579735857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,20705,76,0.82 [0.36-1.86],0.6322579796764716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21257,77,1.05 [0.51-2.18],0.893879934158793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,21257,77,1.31 [0.98-1.75],0.0684204598487731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,24592,89,1.08 [0.83-1.41],0.5715724727348523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,24520,89,0.54 [0.28-1.07],0.0787471559154337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,20813,78,1.02 [0.77-1.34],0.8975310041946055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,21290,77,0.88 [0.43-1.81],0.7381268903693285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,24534,88,1.40 [0.89-2.19],0.1465146215310172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,20813,78,0.93 [0.50-1.74],0.8235373201109675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,24530,85,1.22 [0.91-1.65],0.1779124346948506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,24534,88,0.87 [0.49-1.53],0.6162492766577934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,24760,86,1.13 [0.79-1.62],0.4869069277072061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,20626,75,1.03 [0.58-1.86],0.9097145789795388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24446,87,0.80 [0.37-1.74],0.5709271404435944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,24639,90,1.05 [0.66-1.65],0.8461081801928322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,21197,76,1.01 [0.87-1.17],0.9099498613913148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,24383,84,0.56 [0.26-1.20],0.1333812971189626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,24562,89,1.15 [0.64-2.08],0.6336660280946167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,24438,86,1.19 [0.67-2.09],0.5527265642104834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,24790,89,1.07 [0.70-1.63],0.7703836117740253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20687,81,1.09 [0.69-1.73],0.7085190817472315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,20537,77,1.07 [0.76-1.50],0.6852021742622525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,20890,76,0.68 [0.47-0.97],0.033395223413068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,21233,77,1.34 [0.97-1.85],0.0762101460941867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,24096,86,1.08 [0.88-1.32],0.4723043138814528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20634,75,0.81 [0.39-1.69],0.5771121198548621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,21233,77,1.24 [0.76-2.02],0.3817893053377612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,24552,89,1.06 [0.91-1.24],0.4464340290951305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,24420,84,1.14 [0.84-1.54],0.3962142767120754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,24530,85,1.08 [0.86-1.34],0.5158346627596773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,21290,77,1.61 [0.85-3.05],0.1458661521920433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,23961,82,1.02 [0.72-1.43],0.9181517714530412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20687,81,1.26 [0.77-2.06],0.3634512871158438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24524,86,1.06 [0.90-1.25],0.4629245181026752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24602,90,0.97 [0.63-1.50],0.8968632590979241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,20537,77,1.12 [0.55-2.28],0.7481801066492622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,21197,76,1.29 [0.86-1.94],0.2151429173123281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,20813,78,1.25 [0.85-1.85],0.2548985917601374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24420,84,1.27 [0.85-1.90],0.2501537407585908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24837,89,1.53 [0.82-2.84],0.1795057988577261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20687,81,1.11 [0.75-1.64],0.6068033974542266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,21283,78,0.88 [0.42-1.82],0.7256508976332933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,21174,77,0.75 [0.40-1.42],0.380654840091216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,24335,83,1.22 [0.90-1.64],0.1986853040417417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,20687,81,1.37 [1.06-1.77],0.0164107726665263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,24420,84,1.11 [0.96-1.27],0.1550866273721503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20537,77,1.11 [0.83-1.50],0.4740043076768311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24776,86,0.91 [0.58-1.42],0.6661447739811901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,24496,88,0.86 [0.41-1.80],0.6834195137516292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,20634,75,1.09 [0.83-1.44],0.5216517793613422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,24490,87,1.29 [0.97-1.70],0.074883267432291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,24111,86,1.27 [0.99-1.64],0.0649416848672972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,23961,82,1.08 [0.79-1.48],0.6247958030925321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,24552,86,1.15 [0.93-1.42],0.2078270649765316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",20537,77,0.85 [0.66-1.10],0.2162505455643688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,23956,85,0.73 [0.50-1.07],0.1051421703875669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,20705,76,1.12 [0.71-1.78],0.6138267478700706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,21233,77,1.10 [0.65-1.86],0.718389648113759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,24420,84,1.05 [0.77-1.42],0.7728069986674623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,20687,81,0.83 [0.46-1.50],0.5468689613084052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,23956,85,0.95 [0.71-1.28],0.7471796463836291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,20687,81,0.86 [0.56-1.33],0.4999646263198333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,24530,85,0.96 [0.65-1.42],0.8392730771877236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,21257,77,0.98 [0.74-1.29],0.8621266513993635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,23956,85,1.12 [0.74-1.70],0.5882329640536025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,21197,76,1.01 [0.60-1.70],0.9766206218634562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,23956,85,1.13 [0.89-1.44],0.3042857896345988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,24776,86,1.08 [0.93-1.26],0.3062042690388185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,24530,85,0.86 [0.60-1.24],0.4183798789544491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,20687,81,1.17 [0.92-1.50],0.2027859863870218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24776,86,1.13 [0.78-1.62],0.5197999590344747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",21257,77,0.85 [0.59-1.23],0.380830267036804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,24111,86,1.01 [0.68-1.51],0.943195834853482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,24534,88,1.12 [0.60-2.11],0.7148494902379523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,21174,77,0.96 [0.56-1.65],0.8783825319857292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,20703,78,1.22 [0.64-2.32],0.5498030454348513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,20705,76,0.86 [0.59-1.25],0.4282372562955089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21197,76,1.47 [0.92-2.34],0.1067437763690077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,20813,78,1.20 [0.83-1.73],0.3368636374117518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20634,75,0.93 [0.61-1.42],0.7530111358556477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,21233,77,1.15 [0.68-1.93],0.6090054522644396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,21290,77,0.97 [0.72-1.31],0.8521681784687294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20890,76,0.94 [0.76-1.15],0.5304234157367507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,24420,84,1.01 [0.86-1.19],0.8644575175065654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,21770,76,1.30 [0.64-2.64],0.4670853139181077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,21174,77,1.35 [0.80-2.26],0.2590920298526782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,24420,84,1.15 [0.64-2.04],0.6455808948618783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,20537,77,1.31 [1.03-1.66],0.02565353646652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,21212,77,1.14 [0.72-1.82],0.5723675552540756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,24096,86,1.32 [1.02-1.70],0.0330015912825506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,20890,76,0.84 [0.54-1.31],0.4395079110045274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,23961,82,1.05 [0.82-1.34],0.69519421853519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20705,76,1.00 [0.75-1.33],0.9871892776534869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21174,77,1.16 [0.67-2.01],0.5957365184333946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,21233,77,0.92 [0.64-1.31],0.6368779504151221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,23961,82,0.77 [0.48-1.25],0.2938986824042286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,24420,84,1.05 [0.85-1.29],0.6677298899302193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,24530,85,1.00 [0.79-1.27],0.9884967638793974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,20813,78,1.24 [0.97-1.58],0.083373242793059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,24383,84,1.05 [0.86-1.27],0.6342995748850482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,24383,84,1.05 [0.83-1.33],0.688841232062217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,23956,85,1.09 [0.87-1.36],0.466381674631504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,20705,76,1.20 [0.82-1.74],0.3502495844594666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,24338,84,1.12 [0.92-1.37],0.2635485925560714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,24111,86,0.95 [0.74-1.23],0.7061974122370266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,20875,79,0.39 [0.20-0.77],0.0067791952209119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,24790,89,0.95 [0.50-1.79],0.8637802106761326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21290,77,1.78 [1.12-2.83],0.0151900133403715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,20890,76,1.13 [0.82-1.55],0.4483192555573011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,21290,77,0.85 [0.42-1.74],0.6608636638599277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,23961,82,1.02 [0.89-1.16],0.8167073930895467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",20705,76,0.57 [0.29-1.15],0.1163191134630256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21174,77,0.91 [0.65-1.25],0.5489801083744331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,23961,82,1.08 [0.86-1.35],0.5018271480467953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,20626,75,1.46 [0.97-2.20],0.0722871790841197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,24592,89,0.66 [0.30-1.48],0.3152305411588094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,20687,81,2.11 [1.26-3.51],0.0043288729813286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,20861,76,1.01 [0.82-1.25],0.8972799287201368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,20705,76,1.05 [0.69-1.59],0.8186165800433413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,20890,76,0.92 [0.51-1.66],0.7810067497164641
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,21319,81,0.53 [0.20-1.39],0.1950364302698611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,20634,75,1.00 [0.68-1.46],0.9879228521137362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,24422,87,1.08 [0.85-1.38],0.5337715539658874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,24603,89,1.21 [0.88-1.66],0.2362292865924478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,24502,88,0.94 [0.59-1.49],0.7928379702324574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,24442,90,0.94 [0.52-1.69],0.8249333096494671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,24508,88,1.13 [0.73-1.75],0.5814656191740778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,24621,90,1.08 [0.66-1.76],0.753725865530622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,21174,77,0.97 [0.79-1.20],0.8000110829167296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,24530,85,1.22 [0.82-1.81],0.3367402610155445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,24792,86,1.05 [0.65-1.72],0.8330379345829756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,21174,77,0.88 [0.58-1.33],0.5441254120447121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,24362,87,1.04 [0.51-2.12],0.914913377444254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,20687,81,1.37 [0.65-2.89],0.4135994263504956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24592,89,0.63 [0.33-1.20],0.159704573004744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,24837,89,0.74 [0.42-1.32],0.310032505682192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,24509,86,1.07 [0.83-1.38],0.6181166720951001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,21298,80,0.98 [0.42-2.31],0.9657835894430632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,20494,77,0.91 [0.69-1.19],0.486518817189561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24552,86,1.03 [0.51-2.08],0.9277275923676112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,24534,88,1.40 [0.85-2.29],0.1870905637572499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,24531,90,1.17 [0.77-1.76],0.4618977168402725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,24452,85,1.27 [0.70-2.29],0.4303770737688527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,24111,86,1.02 [0.62-1.67],0.939200244521726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,20626,75,0.87 [0.68-1.10],0.2494871465580853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,20537,81,0.79 [0.41-1.51],0.4711820519830868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,21133,77,1.14 [0.90-1.46],0.2790074018891662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,24776,86,1.14 [0.56-2.32],0.7088116053385782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,23846,86,1.15 [0.99-1.34],0.0715627883615603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,24837,89,1.03 [0.66-1.62],0.8998476458985817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23913,81,1.09 [0.73-1.62],0.6749897852694562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20890,76,0.84 [0.45-1.60],0.603921778701956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24602,90,1.27 [0.83-1.94],0.2713252615490401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21290,77,0.99 [0.58-1.71],0.980555684421134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21233,77,1.01 [0.79-1.29],0.9524036078803484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,24240,88,1.35 [0.70-2.60],0.3737474368338039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,21290,77,1.64 [0.98-2.74],0.06147203574363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,24639,90,1.12 [0.97-1.28],0.1121440002239541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,24534,88,1.05 [0.65-1.68],0.8464749911272247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,24478,86,0.71 [0.30-1.68],0.4307492910888025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,24592,89,1.03 [0.82-1.29],0.8041311844068924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,20634,75,1.14 [0.70-1.87],0.5941144234518865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",20890,76,1.09 [0.69-1.73],0.7084911164554728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,20687,81,0.86 [0.37-2.00],0.7225824849764086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,20890,76,0.92 [0.35-2.38],0.8602599138513228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,24840,86,1.16 [0.85-1.59],0.3519532736896661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,20687,81,0.69 [0.32-1.50],0.349716665936693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20705,76,1.15 [0.78-1.69],0.4698908420155374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,20890,76,0.93 [0.61-1.42],0.7333965294110946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,20626,75,1.19 [0.85-1.67],0.3022101914570682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,20626,75,1.20 [0.87-1.66],0.2623888357870103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,21197,76,1.03 [0.83-1.27],0.8077305938228493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,21174,77,1.09 [0.82-1.46],0.5470376773144556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,20704,78,1.20 [0.86-1.68],0.2792663066166779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,21257,77,0.72 [0.42-1.23],0.2258621898114219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,20537,77,1.05 [0.61-1.80],0.8516775788392349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,20634,75,0.89 [0.65-1.23],0.4955269276270077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,21185,77,0.96 [0.53-1.74],0.8895364583480933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,24420,84,1.30 [1.05-1.61],0.0151969548801717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,24259,84,1.49 [0.89-2.51],0.1330478108144311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,24534,88,1.24 [0.98-1.57],0.0777980472348214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,24602,90,0.92 [0.62-1.37],0.6856283710951774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24070,86,1.45 [1.04-2.02],0.0281323083995184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21197,76,1.07 [0.71-1.62],0.734074654656944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,24096,86,1.17 [0.70-1.95],0.5575542425856723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20813,78,1.14 [0.82-1.58],0.4249594231683663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24383,84,1.30 [0.73-2.34],0.3759426845715179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24383,84,1.13 [0.78-1.63],0.5107317063425637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24569,87,0.88 [0.60-1.27],0.485717112022495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24840,86,0.74 [0.43-1.26],0.2629936899116969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24518,89,0.49 [0.25-0.94],0.0318064366578266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24592,89,0.89 [0.51-1.53],0.6643332080962685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24562,89,1.20 [0.65-2.22],0.5633217478334145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24096,86,1.24 [0.78-1.95],0.3643485166947511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24562,89,1.22 [0.65-2.30],0.5285039176520403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20813,78,0.83 [0.48-1.45],0.5135226289631649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24760,86,0.85 [0.44-1.66],0.6430108284256739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24534,88,1.44 [0.74-2.81],0.2838040946866923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24534,88,1.17 [0.72-1.91],0.5266519740279114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24776,86,1.18 [0.58-2.40],0.6393168141377669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24792,86,1.21 [0.71-2.06],0.4867257370115537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24383,84,0.96 [0.68-1.37],0.823967912830601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24776,86,1.21 [0.80-1.84],0.3600710516241679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24383,84,1.39 [0.85-2.27],0.1962628073434547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24840,86,1.21 [0.59-2.51],0.6062147720366625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24530,85,1.50 [1.10-2.04],0.0102580443277668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24840,86,1.22 [0.64-2.34],0.545901537747709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24639,90,1.06 [0.53-2.16],0.8618699708793596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24787,89,1.37 [0.68-2.74],0.3740617877404004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,24383,84,0.93 [0.67-1.30],0.672945614503976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21283,78,1.56 [0.87-2.78],0.1322174866494213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,21233,77,0.94 [0.73-1.20],0.6060559527665064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,21283,78,0.95 [0.57-1.57],0.8317808692670794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",24111,86,0.90 [0.73-1.12],0.3522338489620764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,20890,76,0.60 [0.31-1.14],0.1167155168522019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,24383,84,0.93 [0.58-1.47],0.7466613746658104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,24534,88,0.84 [0.40-1.75],0.6337987158403457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21290,77,0.98 [0.73-1.30],0.8642397254605788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,21197,76,0.83 [0.69-1.01],0.0604572291805544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",20537,77,1.16 [0.76-1.76],0.4881159084297879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,20687,81,1.26 [0.98-1.61],0.0677515019658582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,20704,78,1.00 [0.68-1.48],0.9862431055416326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,23956,85,1.07 [0.69-1.65],0.77266183672443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,20687,81,1.08 [0.85-1.36],0.5421246168741518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,20358,77,1.19 [0.80-1.79],0.3898913101550413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,24111,86,1.49 [0.97-2.27],0.0682987845400602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,20705,76,1.23 [0.65-2.34],0.5187357889495037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,20705,76,1.04 [0.61-1.78],0.8729897813871375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,20813,78,1.10 [0.90-1.35],0.3566191900023181
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,21290,77,0.89 [0.41-1.90],0.7536429069684785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,20626,75,1.10 [0.68-1.79],0.6886543001876216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,23956,85,1.04 [0.80-1.35],0.7525977843811336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,24367,89,1.08 [0.73-1.59],0.6993812003447968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,20890,76,1.09 [0.84-1.42],0.5162594237922966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,23961,82,0.75 [0.43-1.33],0.3270361282471113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20626,75,1.04 [0.70-1.55],0.8389850549687277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,20537,77,1.10 [0.81-1.50],0.5320193754437692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,24800,86,1.22 [0.85-1.76],0.274025726351465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,21257,77,0.59 [0.29-1.21],0.1520724066884661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,20687,81,2.08 [1.33-3.27],0.0014692766113693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,24096,86,0.76 [0.52-1.10],0.1388203508534934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,24530,85,1.00 [0.76-1.31],0.9932689473002174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20687,81,1.22 [0.79-1.89],0.3728582250894121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20626,75,0.85 [0.50-1.44],0.5469645524375469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20890,76,1.08 [0.83-1.39],0.5739133381050209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,21283,78,1.15 [0.86-1.54],0.345359549987712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,24518,89,1.37 [0.97-1.94],0.074091919389274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,21298,80,1.29 [0.88-1.89],0.1997742391360181
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,24534,88,1.51 [0.86-2.63],0.1508086361443307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24760,86,1.17 [0.87-1.56],0.2978166604222247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,24530,85,0.93 [0.72-1.21],0.6016643521817404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,20844,76,0.82 [0.58-1.16],0.2676786500799106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21197,76,1.08 [0.89-1.32],0.4391163701438056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,20537,77,1.06 [0.74-1.51],0.758239231013431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,20705,76,0.93 [0.68-1.26],0.6301034508350556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,24530,85,1.00 [0.80-1.24],0.9822281803273946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,21174,77,0.99 [0.77-1.28],0.9597960309492064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,20626,75,1.04 [0.67-1.62],0.8655619054062655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,20687,81,0.93 [0.69-1.27],0.656762370825773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,21257,77,1.00 [0.73-1.38],0.986745481591426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,24552,86,0.87 [0.67-1.12],0.2775605889019248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,24111,86,1.03 [0.76-1.40],0.8578451430245977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,20626,75,0.92 [0.52-1.61],0.7697770843443175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,24111,86,1.30 [0.90-1.90],0.1652502703872374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,20626,75,0.92 [0.56-1.48],0.7182718165855453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,20634,75,0.90 [0.69-1.16],0.4039642151793041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,21197,76,0.94 [0.75-1.18],0.5793444772897258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,20687,81,1.42 [0.88-2.29],0.1512977368427663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,23930,82,0.98 [0.76-1.27],0.8943963817174964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,20705,76,1.14 [0.74-1.75],0.5577275207245926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,20626,75,0.97 [0.71-1.35],0.872792346456317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,21087,81,0.79 [0.34-1.84],0.5872607269777395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,20634,75,0.99 [0.45-2.21],0.9841635904977388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,21283,78,1.09 [0.85-1.40],0.4900433307614427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,20890,76,1.22 [0.97-1.54],0.088995494590907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,24383,84,1.10 [0.88-1.37],0.3907680223825284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,20941,78,1.17 [0.74-1.87],0.5047484666612316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,24592,89,0.71 [0.36-1.37],0.3056659859559975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,24776,86,1.36 [1.05-1.76],0.0215842445705451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,21233,77,1.05 [0.71-1.57],0.802223741860325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,20597,75,0.90 [0.70-1.16],0.4362700207384851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24534,88,1.29 [0.88-1.90],0.1959117218811909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,24401,85,1.23 [0.93-1.62],0.1459347246167627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,24552,86,0.69 [0.35-1.35],0.2792698991104034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20687,81,1.10 [0.77-1.56],0.6114988158709779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,24420,84,1.16 [0.66-2.02],0.6052371750113122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,21174,77,1.42 [0.72-2.81],0.3065550194838871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21290,77,1.22 [0.87-1.71],0.2565278319373308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20687,81,1.25 [0.93-1.69],0.1430431626049262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,20626,75,0.84 [0.50-1.44],0.534781961029944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,20813,78,1.31 [0.97-1.76],0.0780863531476812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21197,76,1.03 [0.88-1.20],0.7251541270920837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,20626,75,0.86 [0.65-1.12],0.2620735984647744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,20626,75,0.97 [0.50-1.89],0.9370843526569448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,24383,84,1.14 [0.68-1.94],0.6159780611453936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,24751,89,1.09 [0.76-1.56],0.6340861590944814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,20687,81,0.84 [0.37-1.91],0.6812161956980392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,20537,77,1.01 [0.69-1.49],0.9454325086807004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,21174,77,1.46 [0.95-2.27],0.0879303053004162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,21290,77,0.90 [0.70-1.15],0.3963499275444113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,20634,75,0.96 [0.60-1.54],0.8735753997185208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,20854,76,1.04 [0.71-1.53],0.8210542097997611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,20813,78,1.27 [0.93-1.73],0.1281520902476374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,20705,76,0.81 [0.57-1.16],0.2470764610915424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,24420,84,1.17 [0.94-1.45],0.1485082489853473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,21174,77,1.10 [0.82-1.48],0.516784095858305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,21233,77,1.38 [0.87-2.19],0.1732953244102908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,20626,75,0.95 [0.74-1.24],0.7239712540044629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,24111,86,1.19 [0.99-1.44],0.0692825262966999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,23956,85,1.01 [0.70-1.46],0.9635754568512096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,24111,86,0.97 [0.67-1.40],0.879660330118788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,20687,81,1.11 [0.87-1.40],0.4034741045271872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,24530,85,1.05 [0.83-1.32],0.7075693627478321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,24130,86,1.09 [0.55-2.18],0.802165548213555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,21298,80,1.18 [0.89-1.57],0.2551855436094986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24420,84,1.26 [0.48-3.31],0.6404192126428189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,20634,75,1.02 [0.82-1.27],0.84961979252115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24573,90,0.98 [0.48-1.99],0.956828454443994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,24776,86,1.11 [0.59-2.10],0.7440552566089566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,20537,77,0.85 [0.63-1.15],0.2939528082542098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,24761,86,1.23 [0.89-1.68],0.2056698046414342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,20687,81,0.97 [0.46-2.06],0.9437439897871188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,24592,89,1.12 [0.80-1.56],0.5083150327574659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,24800,86,1.28 [0.74-2.20],0.3796949975962422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,21257,77,1.29 [0.63-2.62],0.4862484796587046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,24111,86,1.00 [0.85-1.17],0.9687689037049032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,20704,78,1.46 [0.73-2.92],0.2830443227853764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,21290,77,1.55 [0.87-2.78],0.1394214382015417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,24420,84,1.04 [0.78-1.39],0.7954248016556417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,21298,80,0.88 [0.66-1.17],0.388299386033797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,24420,84,0.92 [0.61-1.39],0.6955357779359722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,20890,76,0.88 [0.63-1.24],0.4665178828538807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,24420,84,1.07 [0.85-1.36],0.5575023776981474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,21174,77,1.02 [0.82-1.28],0.8474670170837959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,24420,84,1.20 [0.94-1.52],0.1442867356446783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,21174,77,0.69 [0.34-1.38],0.2898386443493267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20626,75,1.04 [0.54-1.97],0.9149043369650584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,21174,77,1.12 [0.76-1.64],0.5616908972221045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24496,88,1.12 [0.69-1.83],0.6446841619977972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24517,86,1.18 [0.89-1.58],0.2551535503654056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,21233,77,0.72 [0.39-1.31],0.2801269725122327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,23961,82,0.94 [0.63-1.41],0.7555610347348297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,20890,76,0.95 [0.55-1.64],0.847889608293779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,24111,86,1.05 [0.76-1.46],0.7631578909341294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24776,86,1.31 [1.01-1.70],0.0415218234743853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,23956,85,0.78 [0.41-1.48],0.4474264035484734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20813,78,1.02 [0.70-1.47],0.9316657344682756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,24728,86,1.14 [0.74-1.76],0.5545360307944637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,20537,77,0.90 [0.65-1.24],0.5033700067341482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,24294,83,0.96 [0.58-1.60],0.8751242484489549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,21257,77,0.79 [0.45-1.37],0.3990770781734987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,24837,89,0.89 [0.69-1.14],0.3642896103810844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24534,88,1.73 [1.06-2.85],0.0296053226311401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,24096,86,0.93 [0.69-1.24],0.6077261198767054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,24111,86,1.13 [0.92-1.37],0.2389124654051844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,23961,82,1.01 [0.80-1.27],0.9297543554294936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,21233,77,0.97 [0.73-1.29],0.8542889132991558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,20687,81,1.17 [0.88-1.56],0.2806018012679565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,21174,77,1.32 [0.81-2.13],0.2647003559122651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,20759,77,1.00 [0.66-1.53],0.9857056533309116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,24718,86,0.93 [0.68-1.26],0.6191363993007377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23252,84,0.81 [0.47-1.42],0.4659178687876405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24306,84,0.94 [0.58-1.51],0.7943315546319872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24562,89,0.96 [0.55-1.67],0.8822222506528913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,24760,86,0.88 [0.50-1.53],0.6424305506694725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,24096,86,0.73 [0.36-1.48],0.3796107745460115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24383,84,1.02 [0.71-1.46],0.9209091900646702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,24760,86,0.89 [0.61-1.28],0.520527430925837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,24709,89,0.64 [0.38-1.08],0.0944308211496269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,20687,81,1.34 [0.95-1.88],0.0918206142752273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,24592,89,0.99 [0.82-1.19],0.8995514418225327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,23961,82,1.33 [0.82-2.15],0.2518581790567645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,21233,77,1.38 [0.63-3.03],0.4229530971973585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21197,76,1.05 [0.91-1.22],0.4958598040200538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,24420,84,1.09 [0.92-1.29],0.326224605954947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,21174,77,1.32 [0.71-2.46],0.3743373231463868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,20626,75,1.22 [0.86-1.73],0.2725520880858261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,24096,86,0.96 [0.77-1.20],0.7238904828176584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,20813,78,1.21 [0.91-1.62],0.1853671318576328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,20687,81,2.52 [1.41-4.51],0.0018605346561122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20687,81,1.17 [0.75-1.83],0.4967156627187274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,23956,85,1.07 [0.82-1.39],0.6099454756390691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24111,86,1.29 [0.87-1.91],0.2030161750404172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,20626,75,0.90 [0.60-1.33],0.5842442814057596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,21197,76,1.02 [0.80-1.30],0.8720685798189145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21233,77,0.98 [0.53-1.82],0.96054015322484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,20687,81,1.43 [0.94-2.17],0.090667553727992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,20890,76,1.06 [0.75-1.49],0.7502264392187274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,21174,77,0.95 [0.72-1.26],0.7211993779132215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,21197,76,0.93 [0.67-1.28],0.6484112151612925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21174,77,0.82 [0.54-1.26],0.3675413023349348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,20704,78,1.02 [0.94-1.11],0.6552138787078035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,20537,77,1.01 [0.53-1.93],0.9813060881169892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,20634,75,0.86 [0.65-1.13],0.2814953141882307
